{"gene":"CD247","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":1988,"finding":"CD3-zeta is required for normal intracellular trafficking and cell surface expression of the TCR/CD3 complex; in its absence only small amounts of surface TCR are expressed, but direct cross-linking of the partial receptor can still induce phosphatidylinositol hydrolysis and IL-2 production, demonstrating that CD3-zeta determines the normal intracellular fate of the TCR and plays an important role in physiologically relevant transmembrane signaling.","method":"Chemical mutagenesis of T cell hybridoma to generate CD3-zeta-deficient variant; functional assays (PI hydrolysis, IL-2 production, antigen response)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct loss-of-function in defined cell variant with multiple orthogonal functional readouts; foundational paper replicated by subsequent knockout studies","pmids":["3278811"],"is_preprint":false},{"year":1988,"finding":"The CD3-zeta eta heterodimer form of the TCR complex shows greater coupling to phosphatidylinositol hydrolysis and serine kinase activation than the CD3-zeta homodimer form, indicating differential signal transduction by TCR isoforms containing different zeta-chain dimers.","method":"Isolation of T cell hybridoma variants expressing CD3-zeta2 without CD3-zeta-eta; comparison of signaling outputs (PI hydrolysis, serine kinase, tyrosine kinase activity)","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — isogenic variant comparison with multiple orthogonal biochemical readouts; foundational mechanistic study","pmids":["2845582"],"is_preprint":false},{"year":1989,"finding":"CD3-zeta specifically co-associates with CD16 (FcγRIII) on human NK cells; co-transfection of CD3-zeta cDNA into COS-7 cells permits surface expression of a transmembrane-linked CD16 complex, demonstrating that CD3-zeta can partner with diverse membrane receptors for signal transduction.","method":"Co-immunoprecipitation from NK cell lysates; co-transfection of CD3-zeta cDNA with CD16 in COS-7 cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — reciprocal biochemical association plus reconstitution by co-transfection; replicated in multiple subsequent studies","pmids":["2532305"],"is_preprint":false},{"year":1989,"finding":"CD3-zeta is required for export of the TCR/CD3 complex from the endoplasmic reticulum to the Golgi apparatus; it associates with the pentameric TCR complex (TCRαβ-CD3γδε) in the ER to form the heptameric complex, and without it the complex is retained intracellularly.","method":"Biochemical fractionation and assembly studies in CD3-zeta-deficient Jurkat T cells; analysis of intracellular processing stages","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical reconstitution of assembly steps in human T cells; multiple orthogonal methods","pmids":["2531776"],"is_preprint":false},{"year":1990,"finding":"CD3-eta is produced by alternative splicing from the same gene as CD3-zeta; CD3-eta and CD3-zeta share identical sequences through amino acid 122 but diverge at their C-terminal regions, with CD3-eta lacking one of six cytoplasmic tyrosine residues (Tyr-132) present in CD3-zeta.","method":"Protein microsequencing and cDNA cloning; genomic analysis confirming alternative splicing from a single locus","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein sequencing plus cDNA cloning; confirmed by genomic structure analysis","pmids":["2139725"],"is_preprint":false},{"year":1990,"finding":"CD3-eta is produced by alternative splicing of the same gene as CD3-zeta; exon VIII of CD3-eta is located 4 kb downstream of exon VIII of CD3-zeta and is reached via an alternative splicing acceptor site.","method":"Genomic analysis of murine CD3-eta gene; identification of exon structure and splicing signals","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct genomic structure determination confirming alternative splicing mechanism","pmids":["2150596"],"is_preprint":false},{"year":1991,"finding":"FcεRIγ homodimers can functionally substitute for CD3-zeta in T cells lacking CD3-zeta and CD3-eta: FcεRIγ associates with TCR components to upregulate TCR surface expression and restores coupling of antigen recognition to IL-2 production.","method":"Transfection of FcεRIγ cDNA into CD3-zeta/eta-deficient T cell hybridoma; surface expression and functional assays","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution experiment in defined deficient cell line with functional rescue readout","pmids":["1714902"],"is_preprint":false},{"year":1991,"finding":"Differential signal transduction by TCR isoforms: tyrosine phosphorylation of CD3-zeta but not CD3-eta follows TCR stimulation; both zeta-containing and eta-containing isoforms transmit Ca2+ mobilization, PI turnover, and IL-2 signals, but zeta-specific phosphorylation likely plays a regulatory role.","method":"Stable transfection of CD3-zeta and/or CD3-eta cDNAs into a CD3-zeta/eta-deficient T cell hybridoma; comparison of signaling readouts and tyrosine phosphorylation","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — isogenic reconstitution system with multiple orthogonal signaling readouts","pmids":["1708889"],"is_preprint":false},{"year":1992,"finding":"The CD3-zeta cytoplasmic domain is necessary and sufficient to couple CD2 stimulation to intracellular signaling (Ca2+ flux, protein tyrosine kinase activation, IL-2 secretion), as demonstrated by a CD8α/CD3-zeta chimeric receptor in CD2+CD3- T cells.","method":"Transfection of CD8α-CD3ζ cytoplasmic domain chimeric receptor into CD2+CD3- Jurkat variant; functional assays after CD2 cross-linking","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with chimeric receptor; defined CD3- cell background; multiple functional readouts","pmids":["1351920"],"is_preprint":false},{"year":1992,"finding":"CD2-mediated signaling in T lymphocytes and NK cells depends on the CD3-zeta subunit; in T cells, transfection of transmembrane CD16 (which associates with CD3-zeta homodimers) into TCR-negative Jurkat cells restores CD2 signaling; a truncated CD3-zeta incapable of transducing signals abrogates CD2 signaling.","method":"Transfection of CD16 cDNA into TCR-negative Jurkat cells; transfection of CD2 into T hybridomas bearing full-length or truncated CD3-zeta; co-immunoprecipitation; functional assays","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic epistasis by reconstitution in defined deficient cell lines; multiple orthogonal experiments","pmids":["1346934"],"is_preprint":false},{"year":1992,"finding":"CD3-zeta phosphorylation at Tyr-132 is required for formation of pp21 (the hyperphosphorylated form); multiple tyrosine residues including Tyr-121 contribute to pp21; p59fyn (but not p56lck or p62yes) associates with all TCR isoforms through TCR components distinct from CD3-zeta or CD3-eta.","method":"Site-directed mutagenesis of CD3-zeta tyrosine residues; in vitro and in vivo phosphorylation assays; co-immunoprecipitation","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis combined with in vitro and in vivo phosphorylation assays","pmids":["1531339"],"is_preprint":false},{"year":1992,"finding":"CD3-zeta surface expression enhances CD4-p56lck-mediated upregulation of TCR-CD3 signaling; in mutant cells where CD3-zeta is not properly associated with the TCR-CD3 complex, CD4 cross-linking with CD3 has weaker effects on calcium mobilization, CD3-zeta tyrosine phosphorylation, and PLCγ1 tyrosine phosphorylation.","method":"Analysis of HPB-ALL T cell mutants with defective CD3-zeta association; calcium flux measurement; tyrosine phosphorylation assays after CD3/CD4 co-cross-linking","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined cell mutants with multiple functional readouts; single lab","pmids":["1532798"],"is_preprint":false},{"year":1993,"finding":"CD3-zeta/eta gene products are required for efficient generation and/or survival of CD4+CD8+ thymocytes and for normal intrathymic T cell differentiation; CD3-zeta/eta-deficient mice have profound reduction in surface TCR levels and almost no mature single-positive thymocytes, whereas gut intraepithelial lymphocytes use FcεRIγ homodimers as TCR-associated subunits.","method":"Gene targeting (homologous recombination) to generate CD3-zeta/eta-null mice; flow cytometry of thymic and peripheral T cell populations","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with defined phenotype; replicated by two independent labs in the same journal issue","pmids":["8223444","8223495","8223445"],"is_preprint":false},{"year":1993,"finding":"CD3-zeta-deficient mice have impaired T cell development (greatly reduced thymocytes, 5-fold lower TCR expression on peripheral T cells, impaired proliferative response), while TCRγδ+ intestinal intraepithelial lymphocytes are unaffected, indicating CD3-zeta has a critical role in conventional T cell development and signaling but is dispensable for extrathymic IEL maturation.","method":"Gene targeting in ES cells to generate CD3-zeta-specific knockout mice (preserving CD3-eta expression); flow cytometry; proliferation assays","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — targeted knockout with preserved CD3-eta expression; multiple phenotypic readouts","pmids":["8223445"],"is_preprint":false},{"year":1994,"finding":"CD45 protein-tyrosine phosphatase specifically binds to tyrosine-phosphorylated CD3-zeta chain through its catalytic domain, and preferentially dephosphorylates CD3-zeta under conditions that do not significantly affect other cellular proteins, suggesting CD45 terminates T cell responses via CD3-zeta dephosphorylation.","method":"GST-CD45 fusion protein pulldown (including catalytically inactive C828S mutant); in vitro phosphatase assay with purified substrates; specificity controls with LAR PTPase and CD45-LAR hybrids","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution with active-site mutant trapping and substrate-specificity controls","pmids":["7526385"],"is_preprint":false},{"year":1994,"finding":"CD3-eta is not required for thymic positive or negative selection, alloproliferative responses, or CTL function, as demonstrated in CD3-eta-specific knockout mice generated by insertion of a neomycin resistance gene into exon 9 (leaving CD3-zeta intact).","method":"Gene targeting to disrupt CD3-eta only; analysis of T cell development and function; crossing with anti-HY TCR transgenic mice","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout preserving CD3-zeta; thymic selection crosses; multiple functional assays","pmids":["8112294"],"is_preprint":false},{"year":1995,"finding":"Syk and ZAP-70 mediate recruitment of CD4/p56lck to the activated TCR/CD3/zeta complex: tyrosine-phosphorylated ZAP-70 and Syk bind to the SH2 domain of p56lck, and this interaction enables CD4 to associate with antigen-stimulated TCR complexes.","method":"Co-immunoprecipitation after CD3 stimulation of Jurkat cells; phosphopeptide competition assays; co-capping experiments in human T lymphoblasts","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, phosphopeptide competition, co-capping; multiple orthogonal methods","pmids":["7539035"],"is_preprint":false},{"year":1995,"finding":"CD3-zeta undergoes rapid turnover independently from the rest of the TCR-CD3 complex in normal T cells; newly synthesized zeta chain exchanges with complex-associated zeta, and the TCR complex may be transported to the surface via the zeta turnover pathway.","method":"Metabolic pulse-chase labeling in normal T cells; biochemical analysis of surface TCR complex components","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct pulse-chase metabolic labeling; single lab","pmids":["7796297"],"is_preprint":false},{"year":1995,"finding":"Both CD3-epsilon and CD3-zeta cytoplasmic domains can independently generate signals sufficient for T cell development (release of DN to DP block) and function (thymocyte death, mature T cell proliferation) in vivo, with no qualitative differences observed between them.","method":"Tac-CD3epsilon and Tac-CD3zeta transgenes introduced into normal and RAG2-/- mice; in vivo and in vitro cross-linking; functional assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic epistasis in RAG2-deficient background; multiple developmental and functional readouts","pmids":["7719942"],"is_preprint":false},{"year":1996,"finding":"p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated TCR/CD3/zeta complex via interaction with tyrosine-phosphorylated ZAP-70; this mechanism operates for both CD8αα and CD8αβ isoforms.","method":"Co-immunoprecipitation after CD3 stimulation; phosphopeptide competition for p56lck SH2 domain binding; in vivo co-precipitation of TCR with CD8","journal":"European Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo co-IP with peptide competition; single lab, two orthogonal methods","pmids":["8814252"],"is_preprint":false},{"year":1996,"finding":"A mutation in the transmembrane domain of TCR-beta (Tyr to Leu at TM11) causes loose association of CD3-zeta resulting in defective TCR/CD3 assembly, and selectively abolishes activation-induced apoptosis and CD95-L expression without affecting IL-2, CD25/CD69 induction, or TCR downregulation, suggesting a specific CD3-zeta-dependent apoptosis pathway.","method":"Mutagenesis of TCRβ TM domain; transfection into TCRβ-negative Jurkat cells; co-immunoprecipitation; functional assays including apoptosis, IL-2, CD25/CD69","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined TM mutant with multiple orthogonal functional readouts; single lab","pmids":["8940006"],"is_preprint":false},{"year":1997,"finding":"Triggered TCR-CD3 complexes are internalized and rapidly degraded in the lysosomal compartment; lysosomal function inhibitors (bafilomycin A1, folimycin) markedly reduce CD3-zeta degradation and cause accumulation in Lamp1+ vesicles.","method":"FACS on fixed/permeabilized T-APC conjugates; Western blot on cell lysates; pharmacological inhibition of lysosomes; immunofluorescence for Lamp1","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (FACS, WB, pharmacological inhibition, immunofluorescence); clear mechanistic readout","pmids":["9151711"],"is_preprint":false},{"year":1998,"finding":"Impaired association of ZAP-70 with CD3-zeta (despite normal ZAP-70 phosphorylation and normal Ca2+ fluxes) is specifically associated with failure to induce CD95-L and apoptosis upon TCR triggering, suggesting CD3-zeta is required for ZAP-70 recruitment to the membrane leading to a specific apoptosis-signaling pathway.","method":"Co-immunoprecipitation of ZAP-70 with CD3-zeta in apoptosis-deficient TCRβ-TM mutant Jurkat cells; subcellular fractionation; tyrosine phosphorylation assays; Ca2+ flux measurement","journal":"Journal of Experimental Medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus subcellular fractionation; single lab; two orthogonal methods","pmids":["9547330"],"is_preprint":false},{"year":1998,"finding":"CD3-zeta/eta modules are each essential for allelic exclusion at the TCR-beta locus (demonstrated using TCR-beta transgenic mice lacking CD3-epsilon and/or CD3-zeta/eta), but CD3 gene products are dispensable for initiation of V(D)J recombination at TCR loci.","method":"Genetic epistasis using CD3-epsilon- and CD3-zeta/eta-deficient mice harboring TCR-beta transgene; analysis of TCR rearrangement and allelic exclusion","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-knockout genetic epistasis with TCR transgene; defined molecular readout of allelic exclusion","pmids":["9419216"],"is_preprint":false},{"year":1999,"finding":"Absence of all functional CD3-zeta ITAMs does not qualitatively impair TCR signaling or T cell effector functions; CD3-gammadeltaepsilon ITAMs are sufficient for qualitatively normal TCR signaling; CD3-zeta ITAMs only make a quantitative difference at suboptimal peptide concentrations.","method":"Genetic substitution of CD3-zeta chains lacking all or part of ITAMs in P14 TCR transgenic mice; analysis of T cell activation and effector functions","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic substitution with complete ITAM ablation; multiple activation readouts","pmids":["10229184"],"is_preprint":false},{"year":1999,"finding":"Differential CD3-zeta phosphorylation (pp21 vs pp23 forms) is not required for T cell antagonism by altered peptide ligands; CD3-zeta is required for full agonist responses but not for antagonist responses.","method":"CD3-zeta tyrosine-to-phenylalanine mutants expressed in T cells; agonist and antagonist peptide stimulation assays; IL-2 production measurement","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct mutagenesis of all phosphorylatable tyrosines; single lab","pmids":["10395646"],"is_preprint":false},{"year":2000,"finding":"CD4 and TCR-associated CD3-zeta cluster together at the T cell-APC interface coincident with intracellular Ca2+ increases; subsequently, signaling-, costimulation-, and cytoskeleton-dependent processes stabilize CD3-zeta in a single central cluster while CD4 moves to the periphery.","method":"GFP-tagged chimeras; three-dimensional video microscopy; live-cell imaging of T cell-APC conjugates","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — live-cell 3D video microscopy with GFP chimeras; direct visualization of dynamics in intact cell conjugates","pmids":["10958781"],"is_preprint":false},{"year":2001,"finding":"CD38 signaling in T cells does not require the CD3-zeta ITAM cytoplasmic domains; in T cells expressing CD3-zeta lacking the cytoplasmic domain, CD38 cross-linking still induces tyrosine phosphorylation of ZAP-70, LAT, Shc, and activates PKB/Akt and Erk. CD38 is constitutively associated with lipid rafts containing Lck and CD3-zeta; full CD3-zeta phosphorylation occurs only in rafts.","method":"T cells expressing cytoplasmic-domain-truncated CD3-zeta; Western blotting; lipid raft fractionation; methyl-β-cyclodextrin depletion","journal":"Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined truncation mutant cell system; lipid raft fractionation; cholesterol depletion; single lab","pmids":["11689561"],"is_preprint":false},{"year":2002,"finding":"L-Arginine depletion causes decreased CD3-zeta expression in Jurkat T cells through a shorter CD3-zeta mRNA half-life (not decreased transcription rate), reversible by L-Arg replenishment but not other amino acids; the mechanism is sensitive to cycloheximide, suggesting involvement of a labile protein.","method":"Culture of Jurkat cells in L-Arg-free medium; flow cytometry; Western blot; RT-PCR; mRNA stability assays with cycloheximide; transcription rate measurements","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (protein, mRNA, transcription rate, mRNA half-life) in same study; mechanistic pathway defined","pmids":["11950832"],"is_preprint":false},{"year":2003,"finding":"SIV Nef directly binds the CD3-zeta cytoplasmic domain and cooperates with AP-2 clathrin adaptor to induce TCR-CD3 endocytosis; SIV Nef and CD3-zeta cooperate to bind AP-2 via a novel interaction surface distinct from Nef's canonical AP-2-binding determinants.","method":"Co-expression of SIV Nef with CD8-CD3zeta chimera in Jurkat cells; flow cytometry for endocytosis; colocalization with AP-2 by fluorescence microscopy; in vitro binding assays with recombinant proteins","journal":"Journal of Virology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro binding with recombinant proteins plus cell-based functional assays; multiple orthogonal methods","pmids":["12829850"],"is_preprint":false},{"year":2004,"finding":"PD-1 signaling inhibits TCR-mediated phosphorylation of ZAP-70 and its association with CD3-zeta, and attenuates PKCtheta activation; phosphorylated PD-1 ITSM peptide acts as a docking site for SHP-2 and SHP-1 in vitro, while the ITIM peptide associates only with SHP-2.","method":"T cell stimulation assays with PD-1 engagement; phospho-specific Western blotting for ZAP-70 and PKCtheta; co-immunoprecipitation of ZAP-70/CD3-zeta; in vitro peptide-protein binding assays","journal":"FEBS Letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical readouts; in vitro peptide binding; single lab","pmids":["15358536"],"is_preprint":false},{"year":2004,"finding":"H. pylori arginase (RocF) depletes L-arginine from the T cell microenvironment and thereby reduces CD3-zeta expression; the arginase mutant rocF(-) neither depletes L-arginine nor reduces CD3-zeta expression, and arginase inhibitors reverse these events.","method":"Co-culture of Jurkat and normal T cells with wild-type vs. arginase-mutant H. pylori; flow cytometry for CD3-zeta; L-arginine measurement; arginase inhibitor experiments","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic bacterial mutant comparison; pharmacological inhibitor rescue; single lab","pmids":["15210820"],"is_preprint":false},{"year":2005,"finding":"Increased caspase-3 expression and activity in SLE T cells contributes to CD3-zeta degradation; caspase-3 inhibition with Z-DEVD-FMK reduces CD3-zeta proteolysis, restores CD3-zeta expression and its association with lipid rafts, reverses abnormal lipid raft preclustering, and reduces FcRgamma expression in SLE T cells.","method":"Caspase-3 inhibitor treatment of SLE T cells; Western blot for CD3-zeta; lipid raft fractionation; calcium flux measurement; flow cytometry","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitor with multiple orthogonal functional readouts; single lab","pmids":["16116236"],"is_preprint":false},{"year":2006,"finding":"Homozygous Q70X mutation in CD3-zeta causes T-B+NK+ SCID in humans by preventing normal TCR assembly and surface expression; mutant CD3-zeta protein is unstable and rapidly degraded; somatic reversion mutations in CD3-zeta can partially rescue surface TCR expression on a subset of T cells.","method":"Patient genetic analysis; retroviral transduction of mutant CD3-zeta into MA5.8 CD3-zeta-deficient murine T hybridoma; Western blot; metabolic labeling; flow cytometry","journal":"New England Journal of Medicine / Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — human genetic mutation validated by functional rescue assay in defined cell line; metabolic labeling; replicated in two independent patient reports","pmids":["16672702","17170122"],"is_preprint":false},{"year":2008,"finding":"PP2A dephosphorylates Elf-1 at Thr-231 in lupus T cells, leading to decreased nuclear 98-kDa Elf-1 form and its reduced binding to the CD3-zeta promoter, thereby suppressing CD3-zeta gene expression; PP2A suppression restores CD3-zeta and corrects aberrant TCR signaling.","method":"PP2A knockdown/overexpression in SLE T cells; Elf-1 phosphorylation analysis; promoter binding assays; Western blot; flow cytometry","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown plus phosphorylation analysis and promoter binding; single lab","pmids":["18714041"],"is_preprint":false},{"year":2008,"finding":"LAPTM5 negatively regulates surface TCR expression by specifically interacting with CD3-zeta and promoting its lysosomal degradation without affecting CD3-epsilon, CD3-delta, or CD3-gamma; TCR downmodulation requires the polyproline-tyrosine motifs and ubiquitin-interacting motif of LAPTM5.","method":"Co-immunoprecipitation; LAPTM5 knockout/overexpression; Western blot; flow cytometry for surface TCR; mutational analysis of LAPTM5 motifs","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, genetic KO, domain mutants; multiple orthogonal methods; strong specificity controls","pmids":["18619870"],"is_preprint":false},{"year":2008,"finding":"TCR engagement causes the cytoplasmic tails of CD3-epsilon and CD3-zeta to adopt a compact, protease-resistant conformation, suggesting that the conformational change induced upon TCR triggering is transmitted to CD3-zeta cytoplasmic tails.","method":"Protease-sensitivity assay of CD3-epsilon and CD3-zeta cytoplasmic tails upon TCR triggering in T cells","journal":"PLoS ONE","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct biochemical conformational assay; single lab; single method","pmids":["18320063"],"is_preprint":false},{"year":2008,"finding":"CD3-zeta is expressed in hippocampal neurons predominantly in the somatodendritic compartment, particularly at dendritic filopodia and growth cones; siRNA-mediated knockdown of CD3-zeta or expression of ITAM-mutant CD3-zeta increases dendritic arborization, while CD3-zeta antibody-mediated activation reduces it, establishing CD3-zeta as a negative regulator of dendritic development through ITAM-based mechanisms.","method":"siRNA knockdown; overexpression of loss-of-function ITAM mutant; antibody-mediated activation; immunofluorescence; biochemical fractionation of rat brain","journal":"Molecular Biology of the Cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA plus ITAM mutant plus antibody activation; multiple orthogonal approaches; single lab","pmids":["18367546"],"is_preprint":false},{"year":2010,"finding":"CD3-zeta is expressed in retinal ganglion cells (RGCs); CD3-zeta-deficient mice have reduced RGC dendritic motility, increased RGC dendritic density, selectively defective glutamate-receptor-mediated synaptic activity in the retina, and failure of eye-specific segregation of RGC axon projections to the CNS.","method":"CD3-zeta knockout mice; live-cell imaging of dendritic motility; electrophysiology; anatomical tracing of retinal projections","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with multiple orthogonal readouts (imaging, electrophysiology, anatomy); defined cellular expression","pmids":["20188655"],"is_preprint":false},{"year":2010,"finding":"Tyrosine-phosphorylated CD3-zeta accumulates on endosomal vesicles distinct from lysosomes after TCR activation, in addition to plasma membrane phosphorylation; genetically encoded live-cell reporters revealed this intracellular phospho-CD3-zeta pool that may sustain TCR signaling after receptor internalization.","method":"Genetically encoded FRET-based phosphorylation reporters for CD3-zeta; live-cell fluorescence microscopy; pharmacological kinase/phosphatase manipulation","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 / Strong — novel genetically encoded biosensor with live-cell imaging; direct visualization of phosphorylation state and trafficking simultaneously","pmids":["21135224"],"is_preprint":false},{"year":2010,"finding":"CARs containing the CD3-zeta transmembrane domain form a complex with the endogenous TCR; receptor dimerization and interaction with the endogenous TCR complex are required for optimal CAR function; mutations of the CAR TM domain that abrogate these interactions reduce functional capacity.","method":"TM domain mutant CARs expressed in Jurkat cells; cytokine production assays after antigen stimulation; biochemical analysis of complex formation","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — TM domain mutagenesis with functional readout; single lab; cell line model","pmids":["20483753"],"is_preprint":false},{"year":2010,"finding":"NKG2D signaling in T and NK cells initiates Fas ligand/Fas-mediated caspase-3/-7 activation, which causes CD3-zeta degradation and impairs function of TCR, CD16, NKp30, and NKp46 receptors that all signal through CD3-zeta.","method":"NKG2D stimulation of T and NK cells; caspase activation assays; Western blot for CD3-zeta; functional assays for multiple CD3-zeta-dependent receptors; ex vivo analysis of tumor-infiltrating lymphocytes","journal":"Journal of Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic approaches; multiple receptor readouts; single lab","pmids":["20926796"],"is_preprint":false},{"year":2012,"finding":"SAP directly associates with CD3-zeta through the first ITAM of CD3-zeta proximal to the membrane; SAP knockdown reduces Erk, Akt, and PLCγ1 activation and IL-2/IL-4 mRNA induction downstream of TCR-CD3 complex triggering.","method":"Co-immunoprecipitation; direct binding assay; shRNA-mediated SAP knockdown; Western blot for downstream signaling; RT-PCR for cytokine mRNA","journal":"PLoS ONE","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct co-IP with domain mapping; siRNA knockdown with functional readouts; single lab","pmids":["22912825"],"is_preprint":false},{"year":2013,"finding":"LAT acts as a negative feedback regulator of CD3-zeta and ZAP-70 tyrosine phosphorylation; in LAT-deficient Jurkat cells, CD3-zeta and ZAP-70 phosphorylation is augmented and more persistent despite loss of ERK and PLCγ1 activation.","method":"MS-based quantitative phosphoproteomics comparing LAT-sufficient and LAT-deficient Jurkat T cells after TCR stimulation","journal":"PLoS ONE","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — quantitative phosphoproteomics in isogenic cell pair; single lab; single method (MS)","pmids":["24204825"],"is_preprint":false},{"year":2013,"finding":"CD247 (CD3-zeta) deficiency in Dahl salt-sensitive rats causes >99% reduction in circulating CD3+ T cells, significantly blunts renal T cell infiltration after high-salt diet, and reduces mean arterial blood pressure, establishing that functional CD3-zeta-dependent T cells are required for full development of salt-sensitive hypertension.","method":"Zinc-finger nuclease-mediated 11-bp frameshift deletion in CD247 in rat; Western blot confirmation of protein absence; flow cytometry; blood pressure measurement; renal immunohistology","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 / Strong — defined knockout allele confirmed at protein level; multiple orthogonal physiological readouts","pmids":["24343121"],"is_preprint":false},{"year":2014,"finding":"LAPTM5 promotes lysosomal degradation of intracellular (Golgi-localized) CD3-zeta but not of cell-surface CD3-zeta associated with the mature TCR complex; ITAM tyrosine phosphorylation of CD3-zeta is dispensable for LAPTM5-mediated degradation; LAPTM5 and SLAP/c-Cbl function in distinct genetic pathways to negatively regulate TCR expression.","method":"Subcellular fractionation; Golgi-localizing mutant CD3-zeta; CD3-zeta YF mutant (all 6 ITAM tyrosines mutated); Western blot; genetic epistasis with SLAP/c-Cbl knockdown","journal":"Immunology and Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple CD3-zeta mutants and subcellular localization; genetic epistasis; single lab","pmids":["24638062"],"is_preprint":false},{"year":2015,"finding":"Extracellular OAS2 secreted by oral tumors induces caspase-3 activation in T cells, which results in CD3-zeta chain down-regulation; caspase-3 inhibition or OAS2 knockdown restores CD3-zeta expression.","method":"Proteomic identification of OAS2; OAS2 overexpression in HEK293 cells; recombinant OAS2 treatment of T cells; caspase-3 activity assays; caspase-3 inhibitor and siRNA rescue experiments","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein plus siRNA rescue; multiple orthogonal approaches; single lab","pmids":["26595239"],"is_preprint":false},{"year":2021,"finding":"TREM-2 expressed on CD4+ T cells interacts with the CD3-zeta-ZAP70 complex (unlike in myeloid cells where it signals through DAP12); this interaction leads to STAT1/4 activation and T-bet transcription, promoting Th1 responses against M. tuberculosis.","method":"Co-immunoprecipitation of TREM-2 with CD3-zeta and ZAP-70; TREM-2 conditional knockout in CD4+ T cells; Rag2-/- reconstitution with TREM-2-KO vs. WT cells; signaling assays","journal":"Journal of Clinical Investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus conditional KO; multiple in vivo and in vitro approaches; single lab","pmids":["34623322"],"is_preprint":false},{"year":2022,"finding":"Residues in the transmembrane domain of mouse CD3-zeta prevent efficient complex formation with mouse CD16, dampening CD16-mediated NK cell signaling; mutating these mouse CD3-zeta TM residues to those encoded by human CD3-zeta rescues CD16 receptor function, demonstrating that CD3-zeta TM domain structure determines CD16 signaling capacity.","method":"Systematic TM domain mutagenesis; reconstitution of CD16-CD3-zeta complexes; functional NK cell assays; structural modeling of TM domain packing","journal":"Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct mutagenesis rescue experiment with reconstituted receptor function; structural analysis; multiple orthogonal readouts","pmids":["35320345"],"is_preprint":false},{"year":2024,"finding":"CD28 costimulation enhances CAR-NK cell function by creating a platform that recruits LCK and ZAP-70 to CD3-zeta, initiating a signaling cascade; this LCK/CD3-zeta/ZAP-70 axis augments NK cell cytotoxicity and persistence in vivo.","method":"CAR-NK cells with various costimulatory domains; co-immunoprecipitation of LCK and ZAP-70 with CD3-zeta; in vitro cytotoxicity assays; multiple xenograft tumor models","journal":"Cancer Discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with in vivo xenograft validation; single lab; multiple tumor models","pmids":["38900051"],"is_preprint":false}],"current_model":"CD247/CD3-zeta is the principal signal-transducing subunit of the TCR/CD3 complex that is required for assembly and ER-to-Golgi export of the heptameric TCR complex, functions as a signaling platform through its six cytoplasmic ITAM tyrosines that are phosphorylated upon TCR engagement to recruit ZAP-70, can co-associate with diverse immune receptors (CD16, NKp46, TREM-2) in NK cells to mediate their signaling, is regulated post-translationally by CD45-mediated dephosphorylation, caspase-3-mediated cleavage, lysosomal degradation via LAPTM5, and L-arginine availability (which controls mRNA stability), adopts a compact protected conformation upon TCR triggering, accumulates as a phosphorylated pool on endosomes to sustain signaling after internalization, and has roles beyond immunity including negative regulation of dendritic development in neurons through ITAM-based mechanisms."},"narrative":{"mechanistic_narrative":"CD247 (CD3-zeta) is the principal signal-transducing subunit of the T cell antigen receptor that both controls assembly and surface delivery of the TCR/CD3 complex and converts receptor engagement into intracellular signals [PMID:3278811, PMID:2531776]. As an ER-resident assembly checkpoint, CD3-zeta associates with the pentameric TCRαβ-CD3γδε complex to form the heptameric receptor, and in its absence the complex is retained intracellularly so that only small amounts of surface TCR are expressed [PMID:3278811, PMID:2531776]; a human Q70X truncation that destabilizes the protein abolishes TCR assembly and causes T-B+NK+ SCID [PMID:16672702, PMID:17170122]. Signal transduction proceeds through the CD3-zeta cytoplasmic ITAM tyrosines, whose phosphorylation creates docking sites that recruit ZAP-70 and the Lck/ZAP-70-CD4/CD8 module to the engaged receptor; this cytoplasmic domain is necessary and sufficient to couple receptor cross-linking to Ca2+ flux, tyrosine kinase activation, and IL-2 production [PMID:1351920, PMID:7539035, PMID:8814252]. ITAM phosphorylation defines distinct downstream branches, including a CD3-zeta/ZAP-70-dependent route to CD95L induction and activation-induced apoptosis [PMID:9547330], though complete ITAM ablation impairs signaling only quantitatively at low antigen doses because CD3-γδε ITAMs suffice for qualitatively normal responses [PMID:10229184]. CD3-zeta is a versatile signaling adaptor that partners with diverse receptors beyond the TCR — CD16/FcγRIII, NKp46, NKG2D-linked receptors, and TREM-2 in NK and T cells — with transmembrane-domain packing dictating partner-complex formation and signaling capacity [PMID:2532305, PMID:35320345, PMID:20926796, PMID:34623322]. Its activity is heavily controlled post-translationally: CD45 dephosphorylates phospho-CD3-zeta to terminate signaling [PMID:7526385], LAPTM5 routes intracellular CD3-zeta to lysosomal degradation [PMID:18619870, PMID:24638062], caspase-3 cleavage degrades it under disease and tumor conditions [PMID:16116236, PMID:20926796, PMID:26595239], and L-arginine availability governs its mRNA stability [PMID:11950832, PMID:15210820]. CD3-zeta also accumulates as a phosphorylated endosomal pool that sustains signaling after receptor internalization [PMID:21135224] and adopts a compact, protease-resistant conformation upon triggering [PMID:18320063]. Beyond immunity, CD3-zeta is expressed in hippocampal and retinal ganglion neurons where it acts through ITAM-based mechanisms as a negative regulator of dendritic development and is required for normal retinal synaptic activity and eye-specific axonal segregation [PMID:18367546, PMID:20188655].","teleology":[{"year":1988,"claim":"Established that CD3-zeta governs the intracellular fate and surface expression of the TCR while still permitting transmembrane signaling, defining it as more than a passive structural chain.","evidence":"Chemical mutagenesis of a T cell hybridoma to generate a CD3-zeta-deficient variant with PI hydrolysis and IL-2 readouts","pmids":["3278811"],"confidence":"High","gaps":["Did not resolve which assembly step CD3-zeta controls","Cytoplasmic signaling determinants not yet mapped"]},{"year":1988,"claim":"Showed that different zeta-chain dimers (zeta-zeta vs zeta-eta) couple differentially to downstream signaling, revealing TCR isoform heterogeneity in signal output.","evidence":"Isogenic T cell hybridoma variants compared for PI hydrolysis and kinase activity","pmids":["2845582"],"confidence":"High","gaps":["Molecular basis of differential coupling unresolved","In vivo relevance of isoforms unclear"]},{"year":1989,"claim":"Defined CD3-zeta as the subunit required for ER-to-Golgi export of the assembled heptameric TCR and as a promiscuous signaling partner for non-TCR receptors such as CD16.","evidence":"Assembly/fractionation in CD3-zeta-deficient Jurkat cells; Co-IP from NK cells with COS-7 reconstitution of CD16","pmids":["2531776","2532305"],"confidence":"High","gaps":["Structural basis of TCR association not determined","Mechanism of CD16 partner selection unknown"]},{"year":1990,"claim":"Demonstrated that CD3-eta arises by alternative splicing of the same gene, explaining the origin of distinct zeta-chain dimers.","evidence":"Protein microsequencing, cDNA cloning, and genomic exon analysis in human and mouse","pmids":["2139725","2150596"],"confidence":"High","gaps":["Functional significance of the missing Tyr-132 in eta not yet tested","Regulation of splice choice unknown"]},{"year":1991,"claim":"Showed that FcεRIγ homodimers can substitute for CD3-zeta and that zeta-specific tyrosine phosphorylation distinguishes zeta from eta, refining the signaling division of labor among related chains.","evidence":"Reconstitution of FcεRIγ and CD3-zeta/eta cDNAs in deficient T cell hybridomas with functional readouts","pmids":["1714902","1708889"],"confidence":"High","gaps":["Why zeta but not eta is phosphorylated not mechanistically defined","Physiological role of zeta-specific phosphorylation unclear"]},{"year":1992,"claim":"Mapped signaling sufficiency to the CD3-zeta cytoplasmic domain and identified specific tyrosines and kinase associations underlying phosphorylation, establishing it as an autonomous signaling module.","evidence":"CD8α-CD3zeta chimeras, site-directed tyrosine mutagenesis, and Co-IP in defined T cell variants","pmids":["1351920","1531339","1346934","1532798"],"confidence":"High","gaps":["Order and hierarchy of ITAM phosphorylation incomplete","Direct kinase responsible for each site not fully assigned"]},{"year":1993,"claim":"Knockout mice established the in vivo requirement for CD3-zeta in conventional thymocyte development and TCR surface expression, while showing it is dispensable for γδ IEL maturation.","evidence":"CD3-zeta/eta-null and CD3-zeta-specific knockout mice analyzed by flow cytometry and proliferation assays","pmids":["8223444","8223495","8223445"],"confidence":"High","gaps":["Did not isolate signaling from assembly contributions to the phenotype","Compensation by FcεRIγ in IELs not fully quantified"]},{"year":1994,"claim":"Identified CD45 as a phosphatase that binds and selectively dephosphorylates phospho-CD3-zeta, providing a mechanism for terminating TCR signals.","evidence":"GST-CD45 pulldowns with active-site mutant trapping and in vitro phosphatase assays with specificity controls","pmids":["7526385"],"confidence":"High","gaps":["In vivo timing of CD45 action on CD3-zeta not established","Site specificity among the six tyrosines not resolved"]},{"year":1995,"claim":"Showed that ZAP-70/Syk phosphorylation recruits Lck-bound CD4/CD8 coreceptors to the activated complex and that CD3-zeta turns over independently of the rest of the TCR, linking phosphorylation to coreceptor assembly and receptor dynamics.","evidence":"Co-IP, phosphopeptide competition, co-capping, and pulse-chase metabolic labeling in human T cells","pmids":["7539035","7796297"],"confidence":"High","gaps":["Quantitative contribution of independent zeta turnover to surface TCR unclear","Trafficking route of exchanging zeta not defined"]},{"year":1995,"claim":"Demonstrated functional redundancy between CD3-epsilon and CD3-zeta cytoplasmic domains for development and effector function in vivo, and showed CD3-eta is dispensable for selection.","evidence":"Tac-CD3 chimeric transgenes in RAG2-/- mice and CD3-eta-specific knockout mice with selection crosses","pmids":["7719942","8112294"],"confidence":"High","gaps":["Quantitative versus qualitative roles not separated","Specialized branches unique to zeta not addressed here"]},{"year":1996,"claim":"Connected defective CD3-zeta association to a selective loss of activation-induced apoptosis, suggesting a dedicated CD3-zeta-dependent death-signaling branch.","evidence":"TCRβ transmembrane mutant abolishing zeta association in Jurkat cells with apoptosis and activation readouts; CD8/p56lck recruitment via ZAP-70","pmids":["8940006","8814252"],"confidence":"Medium","gaps":["Single transmembrane-mutant model; not independently confirmed","Molecular separation of apoptosis from IL-2 pathways incomplete"]},{"year":1997,"claim":"Established lysosomal degradation as the fate of internalized triggered TCR-CD3 complexes, defining a post-activation downmodulation route for CD3-zeta.","evidence":"FACS on T-APC conjugates, Western blot, lysosomal inhibitors, and Lamp1 immunofluorescence","pmids":["9151711"],"confidence":"High","gaps":["Ubiquitin/adaptor machinery not yet identified","Quantitative recycling versus degradation balance unknown"]},{"year":1998,"claim":"Linked impaired ZAP-70 recruitment to CD3-zeta with selective failure of apoptosis signaling, reinforcing a membrane-recruitment requirement for the death branch.","evidence":"Co-IP and subcellular fractionation in apoptosis-deficient TCRβ-TM mutant Jurkat cells","pmids":["9547330"],"confidence":"Medium","gaps":["Single lab and mutant system","Downstream death effectors not mapped"]},{"year":1998,"claim":"Defined an additional developmental role for CD3-zeta/eta modules in TCR-beta allelic exclusion, distinct from V(D)J initiation.","evidence":"Genetic epistasis in CD3-epsilon- and CD3-zeta/eta-deficient mice carrying a TCR-beta transgene","pmids":["9419216"],"confidence":"High","gaps":["Signaling output mediating exclusion not defined","Role of individual ITAMs untested"]},{"year":1999,"claim":"Showed that complete CD3-zeta ITAM ablation impairs signaling only quantitatively at suboptimal ligand, establishing CD3-γδε ITAMs as sufficient for qualitatively normal responses.","evidence":"In vivo genetic ITAM substitution in P14 TCR transgenic mice; tyrosine-to-phenylalanine mutants in antagonism assays","pmids":["10229184","10395646"],"confidence":"High","gaps":["Threshold-tuning mechanism by zeta ITAMs not detailed","Context-dependence in primary cells incompletely explored"]},{"year":2000,"claim":"Visualized the spatial dynamics of CD3-zeta and CD4 clustering at the T cell-APC interface, linking receptor reorganization to early calcium signaling.","evidence":"GFP chimeras and 3D live-cell video microscopy of T cell-APC conjugates","pmids":["10958781"],"confidence":"High","gaps":["Molecular drivers of central cluster stabilization not identified","Relationship to phosphorylation kinetics not resolved"]},{"year":2002,"claim":"Identified L-arginine availability as a metabolic control of CD3-zeta abundance acting through mRNA half-life, later shown to be exploited by H. pylori arginase.","evidence":"L-Arg depletion in Jurkat cells with mRNA stability, transcription rate, and cycloheximide assays; isogenic arginase-mutant bacteria","pmids":["11950832","15210820"],"confidence":"High","gaps":["Identity of the labile regulatory protein unknown","RNA element/binding factor controlling stability not defined"]},{"year":2003,"claim":"Revealed that SIV Nef directly binds the CD3-zeta cytoplasmic tail and cooperates with AP-2 to drive TCR endocytosis, defining a viral immune-evasion mechanism targeting CD3-zeta.","evidence":"CD8-CD3zeta chimera with Nef in Jurkat cells; AP-2 colocalization and in vitro recombinant binding assays","pmids":["12829850"],"confidence":"High","gaps":["Structural basis of the composite Nef/zeta/AP-2 surface not solved","Relevance to HIV-1 Nef not addressed"]},{"year":2004,"claim":"Showed that PD-1 engagement inhibits ZAP-70 phosphorylation and its association with CD3-zeta, placing CD3-zeta at the receiving end of an inhibitory checkpoint.","evidence":"PD-1 engagement assays with phospho-Western blots, Co-IP, and in vitro ITSM/ITIM peptide-SHP binding","pmids":["15358536"],"confidence":"Medium","gaps":["Direct phosphatase action on CD3-zeta versus ZAP-70 not separated","Single lab"]},{"year":2006,"claim":"Linked a human CD3-zeta truncation mutation directly to SCID via failed TCR assembly and protein instability, with somatic reversion partially rescuing surface TCR.","evidence":"Patient genetics with retroviral reconstitution in CD3-zeta-deficient hybridoma, metabolic labeling, and flow cytometry","pmids":["16672702","17170122"],"confidence":"High","gaps":["Genotype-phenotype variability across patients not fully explained","Basis of mutant instability not structurally defined"]},{"year":2008,"claim":"Defined multiple disease-relevant control points of CD3-zeta abundance — PP2A/Elf-1 transcriptional control and caspase-3 degradation in lupus, and LAPTM5-mediated lysosomal degradation.","evidence":"PP2A and Elf-1 manipulation with promoter-binding assays in SLE T cells; caspase-3 inhibition; LAPTM5 Co-IP, KO, and domain mutants","pmids":["18714041","16116236","18619870"],"confidence":"High","gaps":["Relative contribution of transcriptional versus degradative control in vivo unclear","LAPTM5 recognition determinant on CD3-zeta not mapped"]},{"year":2008,"claim":"Provided biochemical evidence that TCR triggering imposes a compact, protease-resistant conformation on the CD3-zeta cytoplasmic tail, suggesting allosteric coupling of engagement to the tail.","evidence":"Protease-sensitivity assay of CD3-epsilon and CD3-zeta tails after TCR triggering","pmids":["18320063"],"confidence":"Medium","gaps":["Single biochemical method; structural model lacking","Functional consequence of conformational change untested"]},{"year":2008,"claim":"Extended CD3-zeta function beyond immunity, identifying it as an ITAM-dependent negative regulator of dendritic development in hippocampal neurons.","evidence":"siRNA knockdown, ITAM-mutant overexpression, and antibody activation with immunofluorescence in neurons","pmids":["18367546"],"confidence":"Medium","gaps":["Neuronal upstream receptor and kinase not identified","Single lab"]},{"year":2010,"claim":"Established neuronal requirement for CD3-zeta in retinal dendritic motility, synaptic activity, and eye-specific axon segregation, and revealed an endosomal phospho-CD3-zeta pool sustaining signaling after internalization.","evidence":"CD3-zeta knockout mice with imaging, electrophysiology, and tracing; FRET phosphorylation biosensors with live-cell imaging","pmids":["20188655","21135224"],"confidence":"High","gaps":["Neuronal ligand and signaling cascade undefined","Functional role of the endosomal phospho-pool not directly perturbed"]},{"year":2010,"claim":"Showed that the CD3-zeta transmembrane domain mediates CAR association with endogenous TCR and that NKG2D-triggered caspase activity degrades CD3-zeta to impair multiple shared receptors.","evidence":"CAR TM-domain mutagenesis with functional readouts; NKG2D stimulation with caspase assays and multi-receptor functional analysis","pmids":["20483753","20926796"],"confidence":"Medium","gaps":["Single labs; cell-line models","Generality of TM-mediated complex formation across CAR designs limited"]},{"year":2012,"claim":"Identified SAP as a direct membrane-proximal ITAM-binding partner of CD3-zeta required for full downstream TCR signaling.","evidence":"Co-IP with domain mapping and shRNA knockdown with downstream signaling and cytokine readouts","pmids":["22912825"],"confidence":"Medium","gaps":["Single lab; no reciprocal in vivo validation","Competition with ZAP-70 for the same ITAM not resolved"]},{"year":2013,"claim":"Defined LAT as a negative feedback regulator constraining CD3-zeta and ZAP-70 phosphorylation, refining the kinetics of proximal signaling.","evidence":"Quantitative phosphoproteomics in isogenic LAT-sufficient and LAT-deficient Jurkat cells","pmids":["24204825"],"confidence":"Medium","gaps":["Mechanism of feedback (phosphatase recruitment vs kinase sequestration) not defined","Single method"]},{"year":2014,"claim":"Resolved the substrate specificity of LAPTM5 to intracellular Golgi-localized CD3-zeta, independent of ITAM phosphorylation and genetically distinct from SLAP/c-Cbl.","evidence":"Subcellular fractionation, Golgi-localizing and ITAM-null CD3-zeta mutants, and genetic epistasis with SLAP/c-Cbl","pmids":["24638062"],"confidence":"Medium","gaps":["Recognition motif on CD3-zeta unmapped","Single lab"]},{"year":2013,"claim":"Demonstrated, via a defined rat knockout, that CD3-zeta-dependent T cells are required for full salt-sensitive hypertension, extending CD3-zeta function to cardiovascular disease.","evidence":"Zinc-finger nuclease frameshift in rat CD247 with protein confirmation, flow cytometry, blood pressure, and renal histology","pmids":["24343121"],"confidence":"High","gaps":["Causal T cell subset not identified","Renal antigen/signaling driving infiltration unknown"]},{"year":2021,"claim":"Showed that TREM-2 in CD4+ T cells signals through the CD3-zeta-ZAP-70 complex rather than DAP12, driving Th1 differentiation, expanding the repertoire of CD3-zeta-coupled receptors.","evidence":"Co-IP of TREM-2 with CD3-zeta/ZAP-70 and conditional TREM-2 knockout with Rag2-/- reconstitution","pmids":["34623322"],"confidence":"Medium","gaps":["Structural basis of TREM-2/CD3-zeta coupling unknown","Single lab"]},{"year":2022,"claim":"Established the CD3-zeta transmembrane domain as the structural determinant of CD16 complex formation and NK signaling capacity through species-swap rescue experiments.","evidence":"Systematic TM mutagenesis, reconstituted CD16-CD3-zeta complexes, NK functional assays, and structural modeling","pmids":["35320345"],"confidence":"High","gaps":["Atomic-resolution TM packing not experimentally solved","Generalization to other zeta-partner receptors not tested"]},{"year":2024,"claim":"Showed that CD28 costimulation builds a platform recruiting LCK and ZAP-70 to CD3-zeta to augment CAR-NK cytotoxicity and persistence, applying CD3-zeta proximal signaling logic to engineered cells.","evidence":"CAR-NK cells with varied costimulatory domains, Co-IP of LCK/ZAP-70 with CD3-zeta, cytotoxicity assays, and xenograft models","pmids":["38900051"],"confidence":"Medium","gaps":["Whether CD28 acts on CD3-zeta directly or via complex remodeling unclear","Single lab"]},{"year":null,"claim":"How CD3-zeta transmembrane and cytoplasmic conformational states are coupled to ITAM phosphorylation order, partner-receptor selection, and the balance among its many degradation pathways remains unresolved at structural and quantitative levels.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No atomic structure linking TM packing to signaling-competent complexes","Quantitative hierarchy among CD45, caspase-3, LAPTM5, and arginine-controlled regulation in vivo undefined","Neuronal upstream ligands and effectors of CD3-zeta unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,8,16,24]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,16,42,49]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,3,33]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,26,39]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[3,45]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[39]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[21,35]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,8,16,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,16,39]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[12,13,23]}],"complexes":["TCR/CD3 complex"],"partners":["ZAP-70","LCK","CD45","LAPTM5","CD16","TREM-2","SAP","CD4"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P20963","full_name":"T-cell surface glycoprotein CD3 zeta chain","aliases":["T-cell receptor T3 zeta chain"],"length_aa":164,"mass_kda":18.7,"function":"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD247/CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways (PubMed:1384049, PubMed:1385158, PubMed:2470098, PubMed:7509083). CD247/CD3Z ITAMs phosphorylation creates multiple docking sites for the protein kinase ZAP70 leading to ZAP70 phosphorylation and its conversion into a catalytically active enzyme (PubMed:7509083). Plays an important role in intrathymic T-cell differentiation. Additionally, participates in the activity-dependent synapse formation of retinal ganglion cells (RGCs) in both the retina and dorsal lateral geniculate nucleus (dLGN) (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P20963/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD247","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD247","total_profiled":1310},"omim":[{"mim_id":"617006","title":"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2","url":"https://www.omim.org/entry/617006"},{"mim_id":"615607","title":"IMMUNODEFICIENCY 17; IMD17","url":"https://www.omim.org/entry/615607"},{"mim_id":"611550","title":"NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3","url":"https://www.omim.org/entry/611550"},{"mim_id":"610163","title":"IMMUNODEFICIENCY 25; IMD25","url":"https://www.omim.org/entry/610163"},{"mim_id":"609742","title":"INTERLEUKIN 4-INDUCED GENE 1; IL4I1","url":"https://www.omim.org/entry/609742"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":38.0},{"tissue":"lymphoid tissue","ntpm":150.1}],"url":"https://www.proteinatlas.org/search/CD247"},"hgnc":{"alias_symbol":["CD3H","CD3Q","TCRZ","CD3-ZETA","CD3ZETA"],"prev_symbol":["CD3Z"]},"alphafold":{"accession":"P20963","domains":[{"cath_id":"1.20.5","chopping":"25-57","consensus_level":"medium","plddt":84.6909,"start":25,"end":57}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P20963","model_url":"https://alphafold.ebi.ac.uk/files/AF-P20963-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P20963-F1-predicted_aligned_error_v6.png","plddt_mean":62.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD247","jax_strain_url":"https://www.jax.org/strain/search?query=CD247"},"sequence":{"accession":"P20963","fasta_url":"https://rest.uniprot.org/uniprotkb/P20963.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P20963/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P20963"}},"corpus_meta":[{"pmid":"15358536","id":"PMC_15358536","title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.","date":"2004","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/15358536","citation_count":645,"is_preprint":false},{"pmid":"2532305","id":"PMC_2532305","title":"Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2532305","citation_count":429,"is_preprint":false},{"pmid":"12874210","id":"PMC_12874210","title":"L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12874210","citation_count":391,"is_preprint":false},{"pmid":"11950832","id":"PMC_11950832","title":"Regulation of T cell receptor CD3zeta chain expression by L-arginine.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11950832","citation_count":389,"is_preprint":false},{"pmid":"3278811","id":"PMC_3278811","title":"Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/3278811","citation_count":379,"is_preprint":false},{"pmid":"10958781","id":"PMC_10958781","title":"Differential clustering of CD4 and CD3zeta during T cell recognition.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10958781","citation_count":295,"is_preprint":false},{"pmid":"25520398","id":"PMC_25520398","title":"Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25520398","citation_count":253,"is_preprint":false},{"pmid":"9151711","id":"PMC_9151711","title":"Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9151711","citation_count":251,"is_preprint":false},{"pmid":"8223444","id":"PMC_8223444","title":"T cell development in mice lacking the CD3-zeta/eta gene.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8223444","citation_count":226,"is_preprint":false},{"pmid":"14613988","id":"PMC_14613988","title":"T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.","date":"2003","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/14613988","citation_count":223,"is_preprint":false},{"pmid":"20483753","id":"PMC_20483753","title":"The optimal antigen response of chimeric antigen receptors harboring the CD3zeta transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20483753","citation_count":210,"is_preprint":false},{"pmid":"8223495","id":"PMC_8223495","title":"Abnormal T cell development in CD3-zeta-/- mutant mice and identification of a novel T cell population in the intestine.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8223495","citation_count":184,"is_preprint":false},{"pmid":"15922712","id":"PMC_15922712","title":"L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes.","date":"2005","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15922712","citation_count":182,"is_preprint":false},{"pmid":"8223445","id":"PMC_8223445","title":"Developmental and functional impairment of T cells in mice lacking CD3 zeta chains.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8223445","citation_count":161,"is_preprint":false},{"pmid":"7526385","id":"PMC_7526385","title":"Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7526385","citation_count":152,"is_preprint":false},{"pmid":"24343121","id":"PMC_24343121","title":"CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24343121","citation_count":139,"is_preprint":false},{"pmid":"2845582","id":"PMC_2845582","title":"T cell CD3-zeta eta heterodimer expression and coupling to phosphoinositide hydrolysis.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2845582","citation_count":134,"is_preprint":false},{"pmid":"7539035","id":"PMC_7539035","title":"Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.","date":"1995","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7539035","citation_count":122,"is_preprint":false},{"pmid":"2139725","id":"PMC_2139725","title":"Molecular cloning of the CD3 eta subunit identifies a CD3 zeta-related product in thymus-derived cells.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2139725","citation_count":113,"is_preprint":false},{"pmid":"10906185","id":"PMC_10906185","title":"Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.","date":"2000","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/10906185","citation_count":105,"is_preprint":false},{"pmid":"11300497","id":"PMC_11300497","title":"L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells.","date":"2001","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/11300497","citation_count":103,"is_preprint":false},{"pmid":"7591205","id":"PMC_7591205","title":"Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7591205","citation_count":103,"is_preprint":false},{"pmid":"1346934","id":"PMC_1346934","title":"CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1346934","citation_count":99,"is_preprint":false},{"pmid":"15210820","id":"PMC_15210820","title":"Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta).","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15210820","citation_count":95,"is_preprint":false},{"pmid":"11689561","id":"PMC_11689561","title":"CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11689561","citation_count":88,"is_preprint":false},{"pmid":"10229184","id":"PMC_10229184","title":"Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10229184","citation_count":85,"is_preprint":false},{"pmid":"9515791","id":"PMC_9515791","title":"An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9515791","citation_count":85,"is_preprint":false},{"pmid":"16672702","id":"PMC_16672702","title":"Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency.","date":"2006","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16672702","citation_count":84,"is_preprint":false},{"pmid":"1351920","id":"PMC_1351920","title":"The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation.","date":"1992","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1351920","citation_count":74,"is_preprint":false},{"pmid":"7719942","id":"PMC_7719942","title":"CD3 epsilon and CD3 zeta cytoplasmic domains can independently generate signals for T cell development and function.","date":"1995","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/7719942","citation_count":71,"is_preprint":false},{"pmid":"7796297","id":"PMC_7796297","title":"Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells.","date":"1995","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/7796297","citation_count":70,"is_preprint":false},{"pmid":"18490778","id":"PMC_18490778","title":"Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18490778","citation_count":68,"is_preprint":false},{"pmid":"21135224","id":"PMC_21135224","title":"Imaging T-cell receptor activation reveals accumulation of tyrosine-phosphorylated CD3ζ in the endosomal compartment.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21135224","citation_count":65,"is_preprint":false},{"pmid":"14523017","id":"PMC_14523017","title":"CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14523017","citation_count":65,"is_preprint":false},{"pmid":"1531339","id":"PMC_1531339","title":"Phosphorylation of multiple CD3 zeta tyrosine residues leads to formation of pp21 in vitro and in vivo. Structural changes upon T cell receptor stimulation.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1531339","citation_count":64,"is_preprint":false},{"pmid":"18619870","id":"PMC_18619870","title":"A lysosomal protein negatively regulates surface T cell antigen receptor expression by promoting CD3zeta-chain degradation.","date":"2008","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18619870","citation_count":62,"is_preprint":false},{"pmid":"20188655","id":"PMC_20188655","title":"The immune protein CD3zeta is required for normal development of neural circuits in the retina.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20188655","citation_count":61,"is_preprint":false},{"pmid":"15356098","id":"PMC_15356098","title":"Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15356098","citation_count":59,"is_preprint":false},{"pmid":"17054067","id":"PMC_17054067","title":"Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment.","date":"2006","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17054067","citation_count":58,"is_preprint":false},{"pmid":"24116999","id":"PMC_24116999","title":"CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy.","date":"2014","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24116999","citation_count":58,"is_preprint":false},{"pmid":"1708889","id":"PMC_1708889","title":"Differential signal transduction via T-cell receptor CD3 zeta 2, CD3 zeta-eta, and CD3 eta 2 isoforms.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1708889","citation_count":55,"is_preprint":false},{"pmid":"10910918","id":"PMC_10910918","title":"CD3zeta and CD28 down-modulation on CD8 T cells during viral infection.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10910918","citation_count":53,"is_preprint":false},{"pmid":"16116236","id":"PMC_16116236","title":"Increased caspase-3 expression and activity contribute to reduced CD3zeta expression in systemic lupus erythematosus T cells.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16116236","citation_count":53,"is_preprint":false},{"pmid":"38900051","id":"PMC_38900051","title":"CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.","date":"2024","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/38900051","citation_count":52,"is_preprint":false},{"pmid":"2531776","id":"PMC_2531776","title":"Assembly, intracellular processing, and expression at the cell surface of the human alpha beta T cell receptor/CD3 complex. Function of the CD3-zeta chain.","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2531776","citation_count":50,"is_preprint":false},{"pmid":"1714902","id":"PMC_1714902","title":"The high affinity Fc epsilon receptor gamma subunit (Fc epsilon RI gamma) facilitates T cell receptor expression and antigen/major histocompatibility complex-driven signaling in the absence of CD3 zeta and CD3 eta.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1714902","citation_count":50,"is_preprint":false},{"pmid":"18714041","id":"PMC_18714041","title":"PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18714041","citation_count":49,"is_preprint":false},{"pmid":"17532043","id":"PMC_17532043","title":"Characterization of the CD3zeta, CD3gammadelta and CD3epsilon subunits of the T cell receptor complex in Atlantic salmon.","date":"2007","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17532043","citation_count":49,"is_preprint":false},{"pmid":"7989113","id":"PMC_7989113","title":"The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administration.","date":"1994","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7989113","citation_count":49,"is_preprint":false},{"pmid":"8814252","id":"PMC_8814252","title":"The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.","date":"1996","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8814252","citation_count":49,"is_preprint":false},{"pmid":"9531350","id":"PMC_9531350","title":"Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies.","date":"1998","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/9531350","citation_count":48,"is_preprint":false},{"pmid":"11401315","id":"PMC_11401315","title":"Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients.","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11401315","citation_count":48,"is_preprint":false},{"pmid":"11389026","id":"PMC_11389026","title":"Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11389026","citation_count":48,"is_preprint":false},{"pmid":"10788618","id":"PMC_10788618","title":"SOCS-1 can suppress CD3zeta- and Syk-mediated NF-AT activation in a non-lymphoid cell line.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10788618","citation_count":47,"is_preprint":false},{"pmid":"17170122","id":"PMC_17170122","title":"T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3zeta subunit of the T-cell antigen receptor complex.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17170122","citation_count":47,"is_preprint":false},{"pmid":"11122143","id":"PMC_11122143","title":"Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.","date":"2000","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/11122143","citation_count":47,"is_preprint":false},{"pmid":"10962448","id":"PMC_10962448","title":"An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10962448","citation_count":45,"is_preprint":false},{"pmid":"26355672","id":"PMC_26355672","title":"In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3ζ expression through ELF-1 inhibition.","date":"2015","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26355672","citation_count":44,"is_preprint":false},{"pmid":"9419216","id":"PMC_9419216","title":"The CD3-gammadeltaepsilon and CD3-zeta/eta modules are each essential for allelic exclusion at the T cell receptor beta locus but are both dispensable for the initiation of V to (D)J recombination at the T cell receptor-beta, -gamma, and -delta loci.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9419216","citation_count":44,"is_preprint":false},{"pmid":"15568289","id":"PMC_15568289","title":"Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine.","date":"2004","source":"JPEN. Journal of parenteral and enteral nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/15568289","citation_count":44,"is_preprint":false},{"pmid":"20926796","id":"PMC_20926796","title":"NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20926796","citation_count":42,"is_preprint":false},{"pmid":"11722641","id":"PMC_11722641","title":"Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.","date":"2001","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11722641","citation_count":39,"is_preprint":false},{"pmid":"20400699","id":"PMC_20400699","title":"Variation in the Cd3 zeta (Cd247) gene correlates with altered T cell activation and is associated with autoimmune diabetes.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20400699","citation_count":39,"is_preprint":false},{"pmid":"24778321","id":"PMC_24778321","title":"Gene-modified human α/β-T cells expressing a chimeric CD16-CD3ζ receptor as adoptively transferable effector cells for anticancer monoclonal antibody therapy.","date":"2014","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/24778321","citation_count":39,"is_preprint":false},{"pmid":"12829850","id":"PMC_12829850","title":"Cooperative interactions of simian immunodeficiency virus Nef, AP-2, and CD3-zeta mediate the selective induction of T-cell receptor-CD3 endocytosis.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12829850","citation_count":38,"is_preprint":false},{"pmid":"38493479","id":"PMC_38493479","title":"Integration of ζ-deficient CARs into the CD3ζ gene conveys potent cytotoxicity in T and NK cells.","date":"2024","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/38493479","citation_count":37,"is_preprint":false},{"pmid":"8940006","id":"PMC_8940006","title":"Apoptosis but not other activation events is inhibited by a mutation in the transmembrane domain of T cell receptor beta that impairs CD3zeta association.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8940006","citation_count":37,"is_preprint":false},{"pmid":"8112294","id":"PMC_8112294","title":"Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8112294","citation_count":37,"is_preprint":false},{"pmid":"35388926","id":"PMC_35388926","title":"Advances in CD247.","date":"2022","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35388926","citation_count":35,"is_preprint":false},{"pmid":"1532798","id":"PMC_1532798","title":"CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1532798","citation_count":35,"is_preprint":false},{"pmid":"9569042","id":"PMC_9569042","title":"Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.","date":"1998","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9569042","citation_count":33,"is_preprint":false},{"pmid":"25732729","id":"PMC_25732729","title":"A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25732729","citation_count":31,"is_preprint":false},{"pmid":"8376772","id":"PMC_8376772","title":"CD3 zeta/eta/theta locus is colinear with and transcribed antisense to the gene encoding the transcription factor Oct-1.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8376772","citation_count":31,"is_preprint":false},{"pmid":"2150596","id":"PMC_2150596","title":"CD3 zeta and eta chains are produced by alternative splicing from a common gene.","date":"1990","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2150596","citation_count":30,"is_preprint":false},{"pmid":"17439593","id":"PMC_17439593","title":"Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.","date":"2007","source":"Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus","url":"https://pubmed.ncbi.nlm.nih.gov/17439593","citation_count":30,"is_preprint":false},{"pmid":"35320345","id":"PMC_35320345","title":"The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35320345","citation_count":29,"is_preprint":false},{"pmid":"18320063","id":"PMC_18320063","title":"T cell receptor engagement triggers its CD3epsilon and CD3zeta subunits to adopt a compact, locked conformation.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18320063","citation_count":29,"is_preprint":false},{"pmid":"22460144","id":"PMC_22460144","title":"CD3 ζ defects in systemic lupus erythematosus.","date":"2012","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22460144","citation_count":28,"is_preprint":false},{"pmid":"18367546","id":"PMC_18367546","title":"The signaling adaptor protein CD3zeta is a negative regulator of dendrite development in young neurons.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18367546","citation_count":28,"is_preprint":false},{"pmid":"11839393","id":"PMC_11839393","title":"Modulation of T-cell CD3-zeta chain expression during normal pregnancy.","date":"2002","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11839393","citation_count":28,"is_preprint":false},{"pmid":"31861005","id":"PMC_31861005","title":"CD247 expression is associated with differentiation and classification in ovarian cancer.","date":"2019","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31861005","citation_count":27,"is_preprint":false},{"pmid":"22004975","id":"PMC_22004975","title":"Association of CD247 with systemic lupus erythematosus in Asian populations.","date":"2011","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/22004975","citation_count":27,"is_preprint":false},{"pmid":"10945225","id":"PMC_10945225","title":"DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family.","date":"2000","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/10945225","citation_count":27,"is_preprint":false},{"pmid":"24204825","id":"PMC_24204825","title":"Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3ζ and ZAP-70 tyrosine phosphorylation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24204825","citation_count":27,"is_preprint":false},{"pmid":"26595239","id":"PMC_26595239","title":"Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.","date":"2015","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26595239","citation_count":27,"is_preprint":false},{"pmid":"9547330","id":"PMC_9547330","title":"T cell receptor (TCR) engagement in apoptosis-defective, but interleukin 2 (IL-2)-producing, T cells results in impaired ZAP70/CD3-zeta association.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9547330","citation_count":27,"is_preprint":false},{"pmid":"11391375","id":"PMC_11391375","title":"Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.","date":"2001","source":"Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/11391375","citation_count":26,"is_preprint":false},{"pmid":"17607320","id":"PMC_17607320","title":"B and T lymphocyte attenuator interacts with CD3zeta and inhibits tyrosine phosphorylation of TCRzeta complex during T-cell activation.","date":"2007","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17607320","citation_count":26,"is_preprint":false},{"pmid":"10098746","id":"PMC_10098746","title":"Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.","date":"1999","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10098746","citation_count":26,"is_preprint":false},{"pmid":"25217164","id":"PMC_25217164","title":"SAP-regulated T Cell-APC adhesion and ligation-dependent and -independent Ly108-CD3ζ interactions.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25217164","citation_count":25,"is_preprint":false},{"pmid":"34623322","id":"PMC_34623322","title":"TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34623322","citation_count":25,"is_preprint":false},{"pmid":"23383358","id":"PMC_23383358","title":"T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.","date":"2013","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23383358","citation_count":25,"is_preprint":false},{"pmid":"25569266","id":"PMC_25569266","title":"Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.","date":"2015","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25569266","citation_count":24,"is_preprint":false},{"pmid":"14715568","id":"PMC_14715568","title":"Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis.","date":"2004","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14715568","citation_count":24,"is_preprint":false},{"pmid":"24638062","id":"PMC_24638062","title":"LAPTM5 promotes lysosomal degradation of intracellular CD3ζ but not of cell surface CD3ζ.","date":"2014","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24638062","citation_count":23,"is_preprint":false},{"pmid":"26606254","id":"PMC_26606254","title":"Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26606254","citation_count":23,"is_preprint":false},{"pmid":"22912825","id":"PMC_22912825","title":"The adaptor protein SAP directly associates with CD3ζ chain and regulates T cell receptor signaling.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912825","citation_count":23,"is_preprint":false},{"pmid":"25030361","id":"PMC_25030361","title":"Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chains.","date":"2014","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/25030361","citation_count":23,"is_preprint":false},{"pmid":"9878110","id":"PMC_9878110","title":"Increased Zap-70 association with CD3zeta in CD4 T cells from old mice.","date":"1998","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9878110","citation_count":23,"is_preprint":false},{"pmid":"10395646","id":"PMC_10395646","title":"Differential CD3 zeta phosphorylation is not required for the induction of T cell antagonism by altered peptide ligands.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10395646","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49324,"output_tokens":11831,"usd":0.162718,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23368,"output_tokens":8846,"usd":0.168995,"stage2_stop_reason":"end_turn"},"total_usd":0.331713,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"CD3-zeta is required for normal intracellular trafficking and cell surface expression of the TCR/CD3 complex; in its absence only small amounts of surface TCR are expressed, but direct cross-linking of the partial receptor can still induce phosphatidylinositol hydrolysis and IL-2 production, demonstrating that CD3-zeta determines the normal intracellular fate of the TCR and plays an important role in physiologically relevant transmembrane signaling.\",\n      \"method\": \"Chemical mutagenesis of T cell hybridoma to generate CD3-zeta-deficient variant; functional assays (PI hydrolysis, IL-2 production, antigen response)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct loss-of-function in defined cell variant with multiple orthogonal functional readouts; foundational paper replicated by subsequent knockout studies\",\n      \"pmids\": [\"3278811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The CD3-zeta eta heterodimer form of the TCR complex shows greater coupling to phosphatidylinositol hydrolysis and serine kinase activation than the CD3-zeta homodimer form, indicating differential signal transduction by TCR isoforms containing different zeta-chain dimers.\",\n      \"method\": \"Isolation of T cell hybridoma variants expressing CD3-zeta2 without CD3-zeta-eta; comparison of signaling outputs (PI hydrolysis, serine kinase, tyrosine kinase activity)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — isogenic variant comparison with multiple orthogonal biochemical readouts; foundational mechanistic study\",\n      \"pmids\": [\"2845582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"CD3-zeta specifically co-associates with CD16 (FcγRIII) on human NK cells; co-transfection of CD3-zeta cDNA into COS-7 cells permits surface expression of a transmembrane-linked CD16 complex, demonstrating that CD3-zeta can partner with diverse membrane receptors for signal transduction.\",\n      \"method\": \"Co-immunoprecipitation from NK cell lysates; co-transfection of CD3-zeta cDNA with CD16 in COS-7 cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reciprocal biochemical association plus reconstitution by co-transfection; replicated in multiple subsequent studies\",\n      \"pmids\": [\"2532305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"CD3-zeta is required for export of the TCR/CD3 complex from the endoplasmic reticulum to the Golgi apparatus; it associates with the pentameric TCR complex (TCRαβ-CD3γδε) in the ER to form the heptameric complex, and without it the complex is retained intracellularly.\",\n      \"method\": \"Biochemical fractionation and assembly studies in CD3-zeta-deficient Jurkat T cells; analysis of intracellular processing stages\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical reconstitution of assembly steps in human T cells; multiple orthogonal methods\",\n      \"pmids\": [\"2531776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD3-eta is produced by alternative splicing from the same gene as CD3-zeta; CD3-eta and CD3-zeta share identical sequences through amino acid 122 but diverge at their C-terminal regions, with CD3-eta lacking one of six cytoplasmic tyrosine residues (Tyr-132) present in CD3-zeta.\",\n      \"method\": \"Protein microsequencing and cDNA cloning; genomic analysis confirming alternative splicing from a single locus\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein sequencing plus cDNA cloning; confirmed by genomic structure analysis\",\n      \"pmids\": [\"2139725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD3-eta is produced by alternative splicing of the same gene as CD3-zeta; exon VIII of CD3-eta is located 4 kb downstream of exon VIII of CD3-zeta and is reached via an alternative splicing acceptor site.\",\n      \"method\": \"Genomic analysis of murine CD3-eta gene; identification of exon structure and splicing signals\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct genomic structure determination confirming alternative splicing mechanism\",\n      \"pmids\": [\"2150596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"FcεRIγ homodimers can functionally substitute for CD3-zeta in T cells lacking CD3-zeta and CD3-eta: FcεRIγ associates with TCR components to upregulate TCR surface expression and restores coupling of antigen recognition to IL-2 production.\",\n      \"method\": \"Transfection of FcεRIγ cDNA into CD3-zeta/eta-deficient T cell hybridoma; surface expression and functional assays\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution experiment in defined deficient cell line with functional rescue readout\",\n      \"pmids\": [\"1714902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Differential signal transduction by TCR isoforms: tyrosine phosphorylation of CD3-zeta but not CD3-eta follows TCR stimulation; both zeta-containing and eta-containing isoforms transmit Ca2+ mobilization, PI turnover, and IL-2 signals, but zeta-specific phosphorylation likely plays a regulatory role.\",\n      \"method\": \"Stable transfection of CD3-zeta and/or CD3-eta cDNAs into a CD3-zeta/eta-deficient T cell hybridoma; comparison of signaling readouts and tyrosine phosphorylation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — isogenic reconstitution system with multiple orthogonal signaling readouts\",\n      \"pmids\": [\"1708889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The CD3-zeta cytoplasmic domain is necessary and sufficient to couple CD2 stimulation to intracellular signaling (Ca2+ flux, protein tyrosine kinase activation, IL-2 secretion), as demonstrated by a CD8α/CD3-zeta chimeric receptor in CD2+CD3- T cells.\",\n      \"method\": \"Transfection of CD8α-CD3ζ cytoplasmic domain chimeric receptor into CD2+CD3- Jurkat variant; functional assays after CD2 cross-linking\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with chimeric receptor; defined CD3- cell background; multiple functional readouts\",\n      \"pmids\": [\"1351920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD2-mediated signaling in T lymphocytes and NK cells depends on the CD3-zeta subunit; in T cells, transfection of transmembrane CD16 (which associates with CD3-zeta homodimers) into TCR-negative Jurkat cells restores CD2 signaling; a truncated CD3-zeta incapable of transducing signals abrogates CD2 signaling.\",\n      \"method\": \"Transfection of CD16 cDNA into TCR-negative Jurkat cells; transfection of CD2 into T hybridomas bearing full-length or truncated CD3-zeta; co-immunoprecipitation; functional assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic epistasis by reconstitution in defined deficient cell lines; multiple orthogonal experiments\",\n      \"pmids\": [\"1346934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD3-zeta phosphorylation at Tyr-132 is required for formation of pp21 (the hyperphosphorylated form); multiple tyrosine residues including Tyr-121 contribute to pp21; p59fyn (but not p56lck or p62yes) associates with all TCR isoforms through TCR components distinct from CD3-zeta or CD3-eta.\",\n      \"method\": \"Site-directed mutagenesis of CD3-zeta tyrosine residues; in vitro and in vivo phosphorylation assays; co-immunoprecipitation\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis combined with in vitro and in vivo phosphorylation assays\",\n      \"pmids\": [\"1531339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"CD3-zeta surface expression enhances CD4-p56lck-mediated upregulation of TCR-CD3 signaling; in mutant cells where CD3-zeta is not properly associated with the TCR-CD3 complex, CD4 cross-linking with CD3 has weaker effects on calcium mobilization, CD3-zeta tyrosine phosphorylation, and PLCγ1 tyrosine phosphorylation.\",\n      \"method\": \"Analysis of HPB-ALL T cell mutants with defective CD3-zeta association; calcium flux measurement; tyrosine phosphorylation assays after CD3/CD4 co-cross-linking\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined cell mutants with multiple functional readouts; single lab\",\n      \"pmids\": [\"1532798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD3-zeta/eta gene products are required for efficient generation and/or survival of CD4+CD8+ thymocytes and for normal intrathymic T cell differentiation; CD3-zeta/eta-deficient mice have profound reduction in surface TCR levels and almost no mature single-positive thymocytes, whereas gut intraepithelial lymphocytes use FcεRIγ homodimers as TCR-associated subunits.\",\n      \"method\": \"Gene targeting (homologous recombination) to generate CD3-zeta/eta-null mice; flow cytometry of thymic and peripheral T cell populations\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with defined phenotype; replicated by two independent labs in the same journal issue\",\n      \"pmids\": [\"8223444\", \"8223495\", \"8223445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD3-zeta-deficient mice have impaired T cell development (greatly reduced thymocytes, 5-fold lower TCR expression on peripheral T cells, impaired proliferative response), while TCRγδ+ intestinal intraepithelial lymphocytes are unaffected, indicating CD3-zeta has a critical role in conventional T cell development and signaling but is dispensable for extrathymic IEL maturation.\",\n      \"method\": \"Gene targeting in ES cells to generate CD3-zeta-specific knockout mice (preserving CD3-eta expression); flow cytometry; proliferation assays\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — targeted knockout with preserved CD3-eta expression; multiple phenotypic readouts\",\n      \"pmids\": [\"8223445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD45 protein-tyrosine phosphatase specifically binds to tyrosine-phosphorylated CD3-zeta chain through its catalytic domain, and preferentially dephosphorylates CD3-zeta under conditions that do not significantly affect other cellular proteins, suggesting CD45 terminates T cell responses via CD3-zeta dephosphorylation.\",\n      \"method\": \"GST-CD45 fusion protein pulldown (including catalytically inactive C828S mutant); in vitro phosphatase assay with purified substrates; specificity controls with LAR PTPase and CD45-LAR hybrids\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution with active-site mutant trapping and substrate-specificity controls\",\n      \"pmids\": [\"7526385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"CD3-eta is not required for thymic positive or negative selection, alloproliferative responses, or CTL function, as demonstrated in CD3-eta-specific knockout mice generated by insertion of a neomycin resistance gene into exon 9 (leaving CD3-zeta intact).\",\n      \"method\": \"Gene targeting to disrupt CD3-eta only; analysis of T cell development and function; crossing with anti-HY TCR transgenic mice\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout preserving CD3-zeta; thymic selection crosses; multiple functional assays\",\n      \"pmids\": [\"8112294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Syk and ZAP-70 mediate recruitment of CD4/p56lck to the activated TCR/CD3/zeta complex: tyrosine-phosphorylated ZAP-70 and Syk bind to the SH2 domain of p56lck, and this interaction enables CD4 to associate with antigen-stimulated TCR complexes.\",\n      \"method\": \"Co-immunoprecipitation after CD3 stimulation of Jurkat cells; phosphopeptide competition assays; co-capping experiments in human T lymphoblasts\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, phosphopeptide competition, co-capping; multiple orthogonal methods\",\n      \"pmids\": [\"7539035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"CD3-zeta undergoes rapid turnover independently from the rest of the TCR-CD3 complex in normal T cells; newly synthesized zeta chain exchanges with complex-associated zeta, and the TCR complex may be transported to the surface via the zeta turnover pathway.\",\n      \"method\": \"Metabolic pulse-chase labeling in normal T cells; biochemical analysis of surface TCR complex components\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct pulse-chase metabolic labeling; single lab\",\n      \"pmids\": [\"7796297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Both CD3-epsilon and CD3-zeta cytoplasmic domains can independently generate signals sufficient for T cell development (release of DN to DP block) and function (thymocyte death, mature T cell proliferation) in vivo, with no qualitative differences observed between them.\",\n      \"method\": \"Tac-CD3epsilon and Tac-CD3zeta transgenes introduced into normal and RAG2-/- mice; in vivo and in vitro cross-linking; functional assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic epistasis in RAG2-deficient background; multiple developmental and functional readouts\",\n      \"pmids\": [\"7719942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated TCR/CD3/zeta complex via interaction with tyrosine-phosphorylated ZAP-70; this mechanism operates for both CD8αα and CD8αβ isoforms.\",\n      \"method\": \"Co-immunoprecipitation after CD3 stimulation; phosphopeptide competition for p56lck SH2 domain binding; in vivo co-precipitation of TCR with CD8\",\n      \"journal\": \"European Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo co-IP with peptide competition; single lab, two orthogonal methods\",\n      \"pmids\": [\"8814252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"A mutation in the transmembrane domain of TCR-beta (Tyr to Leu at TM11) causes loose association of CD3-zeta resulting in defective TCR/CD3 assembly, and selectively abolishes activation-induced apoptosis and CD95-L expression without affecting IL-2, CD25/CD69 induction, or TCR downregulation, suggesting a specific CD3-zeta-dependent apoptosis pathway.\",\n      \"method\": \"Mutagenesis of TCRβ TM domain; transfection into TCRβ-negative Jurkat cells; co-immunoprecipitation; functional assays including apoptosis, IL-2, CD25/CD69\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined TM mutant with multiple orthogonal functional readouts; single lab\",\n      \"pmids\": [\"8940006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Triggered TCR-CD3 complexes are internalized and rapidly degraded in the lysosomal compartment; lysosomal function inhibitors (bafilomycin A1, folimycin) markedly reduce CD3-zeta degradation and cause accumulation in Lamp1+ vesicles.\",\n      \"method\": \"FACS on fixed/permeabilized T-APC conjugates; Western blot on cell lysates; pharmacological inhibition of lysosomes; immunofluorescence for Lamp1\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (FACS, WB, pharmacological inhibition, immunofluorescence); clear mechanistic readout\",\n      \"pmids\": [\"9151711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Impaired association of ZAP-70 with CD3-zeta (despite normal ZAP-70 phosphorylation and normal Ca2+ fluxes) is specifically associated with failure to induce CD95-L and apoptosis upon TCR triggering, suggesting CD3-zeta is required for ZAP-70 recruitment to the membrane leading to a specific apoptosis-signaling pathway.\",\n      \"method\": \"Co-immunoprecipitation of ZAP-70 with CD3-zeta in apoptosis-deficient TCRβ-TM mutant Jurkat cells; subcellular fractionation; tyrosine phosphorylation assays; Ca2+ flux measurement\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus subcellular fractionation; single lab; two orthogonal methods\",\n      \"pmids\": [\"9547330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD3-zeta/eta modules are each essential for allelic exclusion at the TCR-beta locus (demonstrated using TCR-beta transgenic mice lacking CD3-epsilon and/or CD3-zeta/eta), but CD3 gene products are dispensable for initiation of V(D)J recombination at TCR loci.\",\n      \"method\": \"Genetic epistasis using CD3-epsilon- and CD3-zeta/eta-deficient mice harboring TCR-beta transgene; analysis of TCR rearrangement and allelic exclusion\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-knockout genetic epistasis with TCR transgene; defined molecular readout of allelic exclusion\",\n      \"pmids\": [\"9419216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Absence of all functional CD3-zeta ITAMs does not qualitatively impair TCR signaling or T cell effector functions; CD3-gammadeltaepsilon ITAMs are sufficient for qualitatively normal TCR signaling; CD3-zeta ITAMs only make a quantitative difference at suboptimal peptide concentrations.\",\n      \"method\": \"Genetic substitution of CD3-zeta chains lacking all or part of ITAMs in P14 TCR transgenic mice; analysis of T cell activation and effector functions\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic substitution with complete ITAM ablation; multiple activation readouts\",\n      \"pmids\": [\"10229184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Differential CD3-zeta phosphorylation (pp21 vs pp23 forms) is not required for T cell antagonism by altered peptide ligands; CD3-zeta is required for full agonist responses but not for antagonist responses.\",\n      \"method\": \"CD3-zeta tyrosine-to-phenylalanine mutants expressed in T cells; agonist and antagonist peptide stimulation assays; IL-2 production measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct mutagenesis of all phosphorylatable tyrosines; single lab\",\n      \"pmids\": [\"10395646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD4 and TCR-associated CD3-zeta cluster together at the T cell-APC interface coincident with intracellular Ca2+ increases; subsequently, signaling-, costimulation-, and cytoskeleton-dependent processes stabilize CD3-zeta in a single central cluster while CD4 moves to the periphery.\",\n      \"method\": \"GFP-tagged chimeras; three-dimensional video microscopy; live-cell imaging of T cell-APC conjugates\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live-cell 3D video microscopy with GFP chimeras; direct visualization of dynamics in intact cell conjugates\",\n      \"pmids\": [\"10958781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CD38 signaling in T cells does not require the CD3-zeta ITAM cytoplasmic domains; in T cells expressing CD3-zeta lacking the cytoplasmic domain, CD38 cross-linking still induces tyrosine phosphorylation of ZAP-70, LAT, Shc, and activates PKB/Akt and Erk. CD38 is constitutively associated with lipid rafts containing Lck and CD3-zeta; full CD3-zeta phosphorylation occurs only in rafts.\",\n      \"method\": \"T cells expressing cytoplasmic-domain-truncated CD3-zeta; Western blotting; lipid raft fractionation; methyl-β-cyclodextrin depletion\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined truncation mutant cell system; lipid raft fractionation; cholesterol depletion; single lab\",\n      \"pmids\": [\"11689561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"L-Arginine depletion causes decreased CD3-zeta expression in Jurkat T cells through a shorter CD3-zeta mRNA half-life (not decreased transcription rate), reversible by L-Arg replenishment but not other amino acids; the mechanism is sensitive to cycloheximide, suggesting involvement of a labile protein.\",\n      \"method\": \"Culture of Jurkat cells in L-Arg-free medium; flow cytometry; Western blot; RT-PCR; mRNA stability assays with cycloheximide; transcription rate measurements\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (protein, mRNA, transcription rate, mRNA half-life) in same study; mechanistic pathway defined\",\n      \"pmids\": [\"11950832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SIV Nef directly binds the CD3-zeta cytoplasmic domain and cooperates with AP-2 clathrin adaptor to induce TCR-CD3 endocytosis; SIV Nef and CD3-zeta cooperate to bind AP-2 via a novel interaction surface distinct from Nef's canonical AP-2-binding determinants.\",\n      \"method\": \"Co-expression of SIV Nef with CD8-CD3zeta chimera in Jurkat cells; flow cytometry for endocytosis; colocalization with AP-2 by fluorescence microscopy; in vitro binding assays with recombinant proteins\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro binding with recombinant proteins plus cell-based functional assays; multiple orthogonal methods\",\n      \"pmids\": [\"12829850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PD-1 signaling inhibits TCR-mediated phosphorylation of ZAP-70 and its association with CD3-zeta, and attenuates PKCtheta activation; phosphorylated PD-1 ITSM peptide acts as a docking site for SHP-2 and SHP-1 in vitro, while the ITIM peptide associates only with SHP-2.\",\n      \"method\": \"T cell stimulation assays with PD-1 engagement; phospho-specific Western blotting for ZAP-70 and PKCtheta; co-immunoprecipitation of ZAP-70/CD3-zeta; in vitro peptide-protein binding assays\",\n      \"journal\": \"FEBS Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical readouts; in vitro peptide binding; single lab\",\n      \"pmids\": [\"15358536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"H. pylori arginase (RocF) depletes L-arginine from the T cell microenvironment and thereby reduces CD3-zeta expression; the arginase mutant rocF(-) neither depletes L-arginine nor reduces CD3-zeta expression, and arginase inhibitors reverse these events.\",\n      \"method\": \"Co-culture of Jurkat and normal T cells with wild-type vs. arginase-mutant H. pylori; flow cytometry for CD3-zeta; L-arginine measurement; arginase inhibitor experiments\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic bacterial mutant comparison; pharmacological inhibitor rescue; single lab\",\n      \"pmids\": [\"15210820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Increased caspase-3 expression and activity in SLE T cells contributes to CD3-zeta degradation; caspase-3 inhibition with Z-DEVD-FMK reduces CD3-zeta proteolysis, restores CD3-zeta expression and its association with lipid rafts, reverses abnormal lipid raft preclustering, and reduces FcRgamma expression in SLE T cells.\",\n      \"method\": \"Caspase-3 inhibitor treatment of SLE T cells; Western blot for CD3-zeta; lipid raft fractionation; calcium flux measurement; flow cytometry\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitor with multiple orthogonal functional readouts; single lab\",\n      \"pmids\": [\"16116236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Homozygous Q70X mutation in CD3-zeta causes T-B+NK+ SCID in humans by preventing normal TCR assembly and surface expression; mutant CD3-zeta protein is unstable and rapidly degraded; somatic reversion mutations in CD3-zeta can partially rescue surface TCR expression on a subset of T cells.\",\n      \"method\": \"Patient genetic analysis; retroviral transduction of mutant CD3-zeta into MA5.8 CD3-zeta-deficient murine T hybridoma; Western blot; metabolic labeling; flow cytometry\",\n      \"journal\": \"New England Journal of Medicine / Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human genetic mutation validated by functional rescue assay in defined cell line; metabolic labeling; replicated in two independent patient reports\",\n      \"pmids\": [\"16672702\", \"17170122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PP2A dephosphorylates Elf-1 at Thr-231 in lupus T cells, leading to decreased nuclear 98-kDa Elf-1 form and its reduced binding to the CD3-zeta promoter, thereby suppressing CD3-zeta gene expression; PP2A suppression restores CD3-zeta and corrects aberrant TCR signaling.\",\n      \"method\": \"PP2A knockdown/overexpression in SLE T cells; Elf-1 phosphorylation analysis; promoter binding assays; Western blot; flow cytometry\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown plus phosphorylation analysis and promoter binding; single lab\",\n      \"pmids\": [\"18714041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LAPTM5 negatively regulates surface TCR expression by specifically interacting with CD3-zeta and promoting its lysosomal degradation without affecting CD3-epsilon, CD3-delta, or CD3-gamma; TCR downmodulation requires the polyproline-tyrosine motifs and ubiquitin-interacting motif of LAPTM5.\",\n      \"method\": \"Co-immunoprecipitation; LAPTM5 knockout/overexpression; Western blot; flow cytometry for surface TCR; mutational analysis of LAPTM5 motifs\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, genetic KO, domain mutants; multiple orthogonal methods; strong specificity controls\",\n      \"pmids\": [\"18619870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TCR engagement causes the cytoplasmic tails of CD3-epsilon and CD3-zeta to adopt a compact, protease-resistant conformation, suggesting that the conformational change induced upon TCR triggering is transmitted to CD3-zeta cytoplasmic tails.\",\n      \"method\": \"Protease-sensitivity assay of CD3-epsilon and CD3-zeta cytoplasmic tails upon TCR triggering in T cells\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biochemical conformational assay; single lab; single method\",\n      \"pmids\": [\"18320063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CD3-zeta is expressed in hippocampal neurons predominantly in the somatodendritic compartment, particularly at dendritic filopodia and growth cones; siRNA-mediated knockdown of CD3-zeta or expression of ITAM-mutant CD3-zeta increases dendritic arborization, while CD3-zeta antibody-mediated activation reduces it, establishing CD3-zeta as a negative regulator of dendritic development through ITAM-based mechanisms.\",\n      \"method\": \"siRNA knockdown; overexpression of loss-of-function ITAM mutant; antibody-mediated activation; immunofluorescence; biochemical fractionation of rat brain\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA plus ITAM mutant plus antibody activation; multiple orthogonal approaches; single lab\",\n      \"pmids\": [\"18367546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CD3-zeta is expressed in retinal ganglion cells (RGCs); CD3-zeta-deficient mice have reduced RGC dendritic motility, increased RGC dendritic density, selectively defective glutamate-receptor-mediated synaptic activity in the retina, and failure of eye-specific segregation of RGC axon projections to the CNS.\",\n      \"method\": \"CD3-zeta knockout mice; live-cell imaging of dendritic motility; electrophysiology; anatomical tracing of retinal projections\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with multiple orthogonal readouts (imaging, electrophysiology, anatomy); defined cellular expression\",\n      \"pmids\": [\"20188655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Tyrosine-phosphorylated CD3-zeta accumulates on endosomal vesicles distinct from lysosomes after TCR activation, in addition to plasma membrane phosphorylation; genetically encoded live-cell reporters revealed this intracellular phospho-CD3-zeta pool that may sustain TCR signaling after receptor internalization.\",\n      \"method\": \"Genetically encoded FRET-based phosphorylation reporters for CD3-zeta; live-cell fluorescence microscopy; pharmacological kinase/phosphatase manipulation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — novel genetically encoded biosensor with live-cell imaging; direct visualization of phosphorylation state and trafficking simultaneously\",\n      \"pmids\": [\"21135224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CARs containing the CD3-zeta transmembrane domain form a complex with the endogenous TCR; receptor dimerization and interaction with the endogenous TCR complex are required for optimal CAR function; mutations of the CAR TM domain that abrogate these interactions reduce functional capacity.\",\n      \"method\": \"TM domain mutant CARs expressed in Jurkat cells; cytokine production assays after antigen stimulation; biochemical analysis of complex formation\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — TM domain mutagenesis with functional readout; single lab; cell line model\",\n      \"pmids\": [\"20483753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NKG2D signaling in T and NK cells initiates Fas ligand/Fas-mediated caspase-3/-7 activation, which causes CD3-zeta degradation and impairs function of TCR, CD16, NKp30, and NKp46 receptors that all signal through CD3-zeta.\",\n      \"method\": \"NKG2D stimulation of T and NK cells; caspase activation assays; Western blot for CD3-zeta; functional assays for multiple CD3-zeta-dependent receptors; ex vivo analysis of tumor-infiltrating lymphocytes\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic approaches; multiple receptor readouts; single lab\",\n      \"pmids\": [\"20926796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SAP directly associates with CD3-zeta through the first ITAM of CD3-zeta proximal to the membrane; SAP knockdown reduces Erk, Akt, and PLCγ1 activation and IL-2/IL-4 mRNA induction downstream of TCR-CD3 complex triggering.\",\n      \"method\": \"Co-immunoprecipitation; direct binding assay; shRNA-mediated SAP knockdown; Western blot for downstream signaling; RT-PCR for cytokine mRNA\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct co-IP with domain mapping; siRNA knockdown with functional readouts; single lab\",\n      \"pmids\": [\"22912825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LAT acts as a negative feedback regulator of CD3-zeta and ZAP-70 tyrosine phosphorylation; in LAT-deficient Jurkat cells, CD3-zeta and ZAP-70 phosphorylation is augmented and more persistent despite loss of ERK and PLCγ1 activation.\",\n      \"method\": \"MS-based quantitative phosphoproteomics comparing LAT-sufficient and LAT-deficient Jurkat T cells after TCR stimulation\",\n      \"journal\": \"PLoS ONE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative phosphoproteomics in isogenic cell pair; single lab; single method (MS)\",\n      \"pmids\": [\"24204825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD247 (CD3-zeta) deficiency in Dahl salt-sensitive rats causes >99% reduction in circulating CD3+ T cells, significantly blunts renal T cell infiltration after high-salt diet, and reduces mean arterial blood pressure, establishing that functional CD3-zeta-dependent T cells are required for full development of salt-sensitive hypertension.\",\n      \"method\": \"Zinc-finger nuclease-mediated 11-bp frameshift deletion in CD247 in rat; Western blot confirmation of protein absence; flow cytometry; blood pressure measurement; renal immunohistology\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — defined knockout allele confirmed at protein level; multiple orthogonal physiological readouts\",\n      \"pmids\": [\"24343121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LAPTM5 promotes lysosomal degradation of intracellular (Golgi-localized) CD3-zeta but not of cell-surface CD3-zeta associated with the mature TCR complex; ITAM tyrosine phosphorylation of CD3-zeta is dispensable for LAPTM5-mediated degradation; LAPTM5 and SLAP/c-Cbl function in distinct genetic pathways to negatively regulate TCR expression.\",\n      \"method\": \"Subcellular fractionation; Golgi-localizing mutant CD3-zeta; CD3-zeta YF mutant (all 6 ITAM tyrosines mutated); Western blot; genetic epistasis with SLAP/c-Cbl knockdown\",\n      \"journal\": \"Immunology and Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple CD3-zeta mutants and subcellular localization; genetic epistasis; single lab\",\n      \"pmids\": [\"24638062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Extracellular OAS2 secreted by oral tumors induces caspase-3 activation in T cells, which results in CD3-zeta chain down-regulation; caspase-3 inhibition or OAS2 knockdown restores CD3-zeta expression.\",\n      \"method\": \"Proteomic identification of OAS2; OAS2 overexpression in HEK293 cells; recombinant OAS2 treatment of T cells; caspase-3 activity assays; caspase-3 inhibitor and siRNA rescue experiments\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein plus siRNA rescue; multiple orthogonal approaches; single lab\",\n      \"pmids\": [\"26595239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TREM-2 expressed on CD4+ T cells interacts with the CD3-zeta-ZAP70 complex (unlike in myeloid cells where it signals through DAP12); this interaction leads to STAT1/4 activation and T-bet transcription, promoting Th1 responses against M. tuberculosis.\",\n      \"method\": \"Co-immunoprecipitation of TREM-2 with CD3-zeta and ZAP-70; TREM-2 conditional knockout in CD4+ T cells; Rag2-/- reconstitution with TREM-2-KO vs. WT cells; signaling assays\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus conditional KO; multiple in vivo and in vitro approaches; single lab\",\n      \"pmids\": [\"34623322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Residues in the transmembrane domain of mouse CD3-zeta prevent efficient complex formation with mouse CD16, dampening CD16-mediated NK cell signaling; mutating these mouse CD3-zeta TM residues to those encoded by human CD3-zeta rescues CD16 receptor function, demonstrating that CD3-zeta TM domain structure determines CD16 signaling capacity.\",\n      \"method\": \"Systematic TM domain mutagenesis; reconstitution of CD16-CD3-zeta complexes; functional NK cell assays; structural modeling of TM domain packing\",\n      \"journal\": \"Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct mutagenesis rescue experiment with reconstituted receptor function; structural analysis; multiple orthogonal readouts\",\n      \"pmids\": [\"35320345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CD28 costimulation enhances CAR-NK cell function by creating a platform that recruits LCK and ZAP-70 to CD3-zeta, initiating a signaling cascade; this LCK/CD3-zeta/ZAP-70 axis augments NK cell cytotoxicity and persistence in vivo.\",\n      \"method\": \"CAR-NK cells with various costimulatory domains; co-immunoprecipitation of LCK and ZAP-70 with CD3-zeta; in vitro cytotoxicity assays; multiple xenograft tumor models\",\n      \"journal\": \"Cancer Discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with in vivo xenograft validation; single lab; multiple tumor models\",\n      \"pmids\": [\"38900051\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD247/CD3-zeta is the principal signal-transducing subunit of the TCR/CD3 complex that is required for assembly and ER-to-Golgi export of the heptameric TCR complex, functions as a signaling platform through its six cytoplasmic ITAM tyrosines that are phosphorylated upon TCR engagement to recruit ZAP-70, can co-associate with diverse immune receptors (CD16, NKp46, TREM-2) in NK cells to mediate their signaling, is regulated post-translationally by CD45-mediated dephosphorylation, caspase-3-mediated cleavage, lysosomal degradation via LAPTM5, and L-arginine availability (which controls mRNA stability), adopts a compact protected conformation upon TCR triggering, accumulates as a phosphorylated pool on endosomes to sustain signaling after internalization, and has roles beyond immunity including negative regulation of dendritic development in neurons through ITAM-based mechanisms.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CD247 (CD3-zeta) is the principal signal-transducing subunit of the T cell antigen receptor that both controls assembly and surface delivery of the TCR/CD3 complex and converts receptor engagement into intracellular signals [#0, #3]. As an ER-resident assembly checkpoint, CD3-zeta associates with the pentameric TCRαβ-CD3γδε complex to form the heptameric receptor, and in its absence the complex is retained intracellularly so that only small amounts of surface TCR are expressed [#0, #3]; a human Q70X truncation that destabilizes the protein abolishes TCR assembly and causes T-B+NK+ SCID [#33]. Signal transduction proceeds through the CD3-zeta cytoplasmic ITAM tyrosines, whose phosphorylation creates docking sites that recruit ZAP-70 and the Lck/ZAP-70-CD4/CD8 module to the engaged receptor; this cytoplasmic domain is necessary and sufficient to couple receptor cross-linking to Ca2+ flux, tyrosine kinase activation, and IL-2 production [#8, #16, #19]. ITAM phosphorylation defines distinct downstream branches, including a CD3-zeta/ZAP-70-dependent route to CD95L induction and activation-induced apoptosis [#22], though complete ITAM ablation impairs signaling only quantitatively at low antigen doses because CD3-γδε ITAMs suffice for qualitatively normal responses [#24]. CD3-zeta is a versatile signaling adaptor that partners with diverse receptors beyond the TCR — CD16/FcγRIII, NKp46, NKG2D-linked receptors, and TREM-2 in NK and T cells — with transmembrane-domain packing dictating partner-complex formation and signaling capacity [#2, #48, #41, #47]. Its activity is heavily controlled post-translationally: CD45 dephosphorylates phospho-CD3-zeta to terminate signaling [#14], LAPTM5 routes intracellular CD3-zeta to lysosomal degradation [#35, #45], caspase-3 cleavage degrades it under disease and tumor conditions [#32, #41, #46], and L-arginine availability governs its mRNA stability [#28, #31]. CD3-zeta also accumulates as a phosphorylated endosomal pool that sustains signaling after receptor internalization [#39] and adopts a compact, protease-resistant conformation upon triggering [#36]. Beyond immunity, CD3-zeta is expressed in hippocampal and retinal ganglion neurons where it acts through ITAM-based mechanisms as a negative regulator of dendritic development and is required for normal retinal synaptic activity and eye-specific axonal segregation [#37, #38].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established that CD3-zeta governs the intracellular fate and surface expression of the TCR while still permitting transmembrane signaling, defining it as more than a passive structural chain.\",\n      \"evidence\": \"Chemical mutagenesis of a T cell hybridoma to generate a CD3-zeta-deficient variant with PI hydrolysis and IL-2 readouts\",\n      \"pmids\": [\"3278811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which assembly step CD3-zeta controls\", \"Cytoplasmic signaling determinants not yet mapped\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Showed that different zeta-chain dimers (zeta-zeta vs zeta-eta) couple differentially to downstream signaling, revealing TCR isoform heterogeneity in signal output.\",\n      \"evidence\": \"Isogenic T cell hybridoma variants compared for PI hydrolysis and kinase activity\",\n      \"pmids\": [\"2845582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of differential coupling unresolved\", \"In vivo relevance of isoforms unclear\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Defined CD3-zeta as the subunit required for ER-to-Golgi export of the assembled heptameric TCR and as a promiscuous signaling partner for non-TCR receptors such as CD16.\",\n      \"evidence\": \"Assembly/fractionation in CD3-zeta-deficient Jurkat cells; Co-IP from NK cells with COS-7 reconstitution of CD16\",\n      \"pmids\": [\"2531776\", \"2532305\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TCR association not determined\", \"Mechanism of CD16 partner selection unknown\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Demonstrated that CD3-eta arises by alternative splicing of the same gene, explaining the origin of distinct zeta-chain dimers.\",\n      \"evidence\": \"Protein microsequencing, cDNA cloning, and genomic exon analysis in human and mouse\",\n      \"pmids\": [\"2139725\", \"2150596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of the missing Tyr-132 in eta not yet tested\", \"Regulation of splice choice unknown\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Showed that FcεRIγ homodimers can substitute for CD3-zeta and that zeta-specific tyrosine phosphorylation distinguishes zeta from eta, refining the signaling division of labor among related chains.\",\n      \"evidence\": \"Reconstitution of FcεRIγ and CD3-zeta/eta cDNAs in deficient T cell hybridomas with functional readouts\",\n      \"pmids\": [\"1714902\", \"1708889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why zeta but not eta is phosphorylated not mechanistically defined\", \"Physiological role of zeta-specific phosphorylation unclear\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Mapped signaling sufficiency to the CD3-zeta cytoplasmic domain and identified specific tyrosines and kinase associations underlying phosphorylation, establishing it as an autonomous signaling module.\",\n      \"evidence\": \"CD8α-CD3zeta chimeras, site-directed tyrosine mutagenesis, and Co-IP in defined T cell variants\",\n      \"pmids\": [\"1351920\", \"1531339\", \"1346934\", \"1532798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order and hierarchy of ITAM phosphorylation incomplete\", \"Direct kinase responsible for each site not fully assigned\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Knockout mice established the in vivo requirement for CD3-zeta in conventional thymocyte development and TCR surface expression, while showing it is dispensable for γδ IEL maturation.\",\n      \"evidence\": \"CD3-zeta/eta-null and CD3-zeta-specific knockout mice analyzed by flow cytometry and proliferation assays\",\n      \"pmids\": [\"8223444\", \"8223495\", \"8223445\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not isolate signaling from assembly contributions to the phenotype\", \"Compensation by FcεRIγ in IELs not fully quantified\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identified CD45 as a phosphatase that binds and selectively dephosphorylates phospho-CD3-zeta, providing a mechanism for terminating TCR signals.\",\n      \"evidence\": \"GST-CD45 pulldowns with active-site mutant trapping and in vitro phosphatase assays with specificity controls\",\n      \"pmids\": [\"7526385\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo timing of CD45 action on CD3-zeta not established\", \"Site specificity among the six tyrosines not resolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showed that ZAP-70/Syk phosphorylation recruits Lck-bound CD4/CD8 coreceptors to the activated complex and that CD3-zeta turns over independently of the rest of the TCR, linking phosphorylation to coreceptor assembly and receptor dynamics.\",\n      \"evidence\": \"Co-IP, phosphopeptide competition, co-capping, and pulse-chase metabolic labeling in human T cells\",\n      \"pmids\": [\"7539035\", \"7796297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of independent zeta turnover to surface TCR unclear\", \"Trafficking route of exchanging zeta not defined\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrated functional redundancy between CD3-epsilon and CD3-zeta cytoplasmic domains for development and effector function in vivo, and showed CD3-eta is dispensable for selection.\",\n      \"evidence\": \"Tac-CD3 chimeric transgenes in RAG2-/- mice and CD3-eta-specific knockout mice with selection crosses\",\n      \"pmids\": [\"7719942\", \"8112294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative versus qualitative roles not separated\", \"Specialized branches unique to zeta not addressed here\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Connected defective CD3-zeta association to a selective loss of activation-induced apoptosis, suggesting a dedicated CD3-zeta-dependent death-signaling branch.\",\n      \"evidence\": \"TCRβ transmembrane mutant abolishing zeta association in Jurkat cells with apoptosis and activation readouts; CD8/p56lck recruitment via ZAP-70\",\n      \"pmids\": [\"8940006\", \"8814252\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single transmembrane-mutant model; not independently confirmed\", \"Molecular separation of apoptosis from IL-2 pathways incomplete\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Established lysosomal degradation as the fate of internalized triggered TCR-CD3 complexes, defining a post-activation downmodulation route for CD3-zeta.\",\n      \"evidence\": \"FACS on T-APC conjugates, Western blot, lysosomal inhibitors, and Lamp1 immunofluorescence\",\n      \"pmids\": [\"9151711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin/adaptor machinery not yet identified\", \"Quantitative recycling versus degradation balance unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Linked impaired ZAP-70 recruitment to CD3-zeta with selective failure of apoptosis signaling, reinforcing a membrane-recruitment requirement for the death branch.\",\n      \"evidence\": \"Co-IP and subcellular fractionation in apoptosis-deficient TCRβ-TM mutant Jurkat cells\",\n      \"pmids\": [\"9547330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab and mutant system\", \"Downstream death effectors not mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined an additional developmental role for CD3-zeta/eta modules in TCR-beta allelic exclusion, distinct from V(D)J initiation.\",\n      \"evidence\": \"Genetic epistasis in CD3-epsilon- and CD3-zeta/eta-deficient mice carrying a TCR-beta transgene\",\n      \"pmids\": [\"9419216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling output mediating exclusion not defined\", \"Role of individual ITAMs untested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed that complete CD3-zeta ITAM ablation impairs signaling only quantitatively at suboptimal ligand, establishing CD3-γδε ITAMs as sufficient for qualitatively normal responses.\",\n      \"evidence\": \"In vivo genetic ITAM substitution in P14 TCR transgenic mice; tyrosine-to-phenylalanine mutants in antagonism assays\",\n      \"pmids\": [\"10229184\", \"10395646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Threshold-tuning mechanism by zeta ITAMs not detailed\", \"Context-dependence in primary cells incompletely explored\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Visualized the spatial dynamics of CD3-zeta and CD4 clustering at the T cell-APC interface, linking receptor reorganization to early calcium signaling.\",\n      \"evidence\": \"GFP chimeras and 3D live-cell video microscopy of T cell-APC conjugates\",\n      \"pmids\": [\"10958781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular drivers of central cluster stabilization not identified\", \"Relationship to phosphorylation kinetics not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified L-arginine availability as a metabolic control of CD3-zeta abundance acting through mRNA half-life, later shown to be exploited by H. pylori arginase.\",\n      \"evidence\": \"L-Arg depletion in Jurkat cells with mRNA stability, transcription rate, and cycloheximide assays; isogenic arginase-mutant bacteria\",\n      \"pmids\": [\"11950832\", \"15210820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the labile regulatory protein unknown\", \"RNA element/binding factor controlling stability not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed that SIV Nef directly binds the CD3-zeta cytoplasmic tail and cooperates with AP-2 to drive TCR endocytosis, defining a viral immune-evasion mechanism targeting CD3-zeta.\",\n      \"evidence\": \"CD8-CD3zeta chimera with Nef in Jurkat cells; AP-2 colocalization and in vitro recombinant binding assays\",\n      \"pmids\": [\"12829850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the composite Nef/zeta/AP-2 surface not solved\", \"Relevance to HIV-1 Nef not addressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed that PD-1 engagement inhibits ZAP-70 phosphorylation and its association with CD3-zeta, placing CD3-zeta at the receiving end of an inhibitory checkpoint.\",\n      \"evidence\": \"PD-1 engagement assays with phospho-Western blots, Co-IP, and in vitro ITSM/ITIM peptide-SHP binding\",\n      \"pmids\": [\"15358536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct phosphatase action on CD3-zeta versus ZAP-70 not separated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked a human CD3-zeta truncation mutation directly to SCID via failed TCR assembly and protein instability, with somatic reversion partially rescuing surface TCR.\",\n      \"evidence\": \"Patient genetics with retroviral reconstitution in CD3-zeta-deficient hybridoma, metabolic labeling, and flow cytometry\",\n      \"pmids\": [\"16672702\", \"17170122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype variability across patients not fully explained\", \"Basis of mutant instability not structurally defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined multiple disease-relevant control points of CD3-zeta abundance — PP2A/Elf-1 transcriptional control and caspase-3 degradation in lupus, and LAPTM5-mediated lysosomal degradation.\",\n      \"evidence\": \"PP2A and Elf-1 manipulation with promoter-binding assays in SLE T cells; caspase-3 inhibition; LAPTM5 Co-IP, KO, and domain mutants\",\n      \"pmids\": [\"18714041\", \"16116236\", \"18619870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of transcriptional versus degradative control in vivo unclear\", \"LAPTM5 recognition determinant on CD3-zeta not mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided biochemical evidence that TCR triggering imposes a compact, protease-resistant conformation on the CD3-zeta cytoplasmic tail, suggesting allosteric coupling of engagement to the tail.\",\n      \"evidence\": \"Protease-sensitivity assay of CD3-epsilon and CD3-zeta tails after TCR triggering\",\n      \"pmids\": [\"18320063\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single biochemical method; structural model lacking\", \"Functional consequence of conformational change untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended CD3-zeta function beyond immunity, identifying it as an ITAM-dependent negative regulator of dendritic development in hippocampal neurons.\",\n      \"evidence\": \"siRNA knockdown, ITAM-mutant overexpression, and antibody activation with immunofluorescence in neurons\",\n      \"pmids\": [\"18367546\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neuronal upstream receptor and kinase not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established neuronal requirement for CD3-zeta in retinal dendritic motility, synaptic activity, and eye-specific axon segregation, and revealed an endosomal phospho-CD3-zeta pool sustaining signaling after internalization.\",\n      \"evidence\": \"CD3-zeta knockout mice with imaging, electrophysiology, and tracing; FRET phosphorylation biosensors with live-cell imaging\",\n      \"pmids\": [\"20188655\", \"21135224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neuronal ligand and signaling cascade undefined\", \"Functional role of the endosomal phospho-pool not directly perturbed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed that the CD3-zeta transmembrane domain mediates CAR association with endogenous TCR and that NKG2D-triggered caspase activity degrades CD3-zeta to impair multiple shared receptors.\",\n      \"evidence\": \"CAR TM-domain mutagenesis with functional readouts; NKG2D stimulation with caspase assays and multi-receptor functional analysis\",\n      \"pmids\": [\"20483753\", \"20926796\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single labs; cell-line models\", \"Generality of TM-mediated complex formation across CAR designs limited\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified SAP as a direct membrane-proximal ITAM-binding partner of CD3-zeta required for full downstream TCR signaling.\",\n      \"evidence\": \"Co-IP with domain mapping and shRNA knockdown with downstream signaling and cytokine readouts\",\n      \"pmids\": [\"22912825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; no reciprocal in vivo validation\", \"Competition with ZAP-70 for the same ITAM not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defined LAT as a negative feedback regulator constraining CD3-zeta and ZAP-70 phosphorylation, refining the kinetics of proximal signaling.\",\n      \"evidence\": \"Quantitative phosphoproteomics in isogenic LAT-sufficient and LAT-deficient Jurkat cells\",\n      \"pmids\": [\"24204825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of feedback (phosphatase recruitment vs kinase sequestration) not defined\", \"Single method\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved the substrate specificity of LAPTM5 to intracellular Golgi-localized CD3-zeta, independent of ITAM phosphorylation and genetically distinct from SLAP/c-Cbl.\",\n      \"evidence\": \"Subcellular fractionation, Golgi-localizing and ITAM-null CD3-zeta mutants, and genetic epistasis with SLAP/c-Cbl\",\n      \"pmids\": [\"24638062\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Recognition motif on CD3-zeta unmapped\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated, via a defined rat knockout, that CD3-zeta-dependent T cells are required for full salt-sensitive hypertension, extending CD3-zeta function to cardiovascular disease.\",\n      \"evidence\": \"Zinc-finger nuclease frameshift in rat CD247 with protein confirmation, flow cytometry, blood pressure, and renal histology\",\n      \"pmids\": [\"24343121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal T cell subset not identified\", \"Renal antigen/signaling driving infiltration unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed that TREM-2 in CD4+ T cells signals through the CD3-zeta-ZAP-70 complex rather than DAP12, driving Th1 differentiation, expanding the repertoire of CD3-zeta-coupled receptors.\",\n      \"evidence\": \"Co-IP of TREM-2 with CD3-zeta/ZAP-70 and conditional TREM-2 knockout with Rag2-/- reconstitution\",\n      \"pmids\": [\"34623322\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of TREM-2/CD3-zeta coupling unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established the CD3-zeta transmembrane domain as the structural determinant of CD16 complex formation and NK signaling capacity through species-swap rescue experiments.\",\n      \"evidence\": \"Systematic TM mutagenesis, reconstituted CD16-CD3-zeta complexes, NK functional assays, and structural modeling\",\n      \"pmids\": [\"35320345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution TM packing not experimentally solved\", \"Generalization to other zeta-partner receptors not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed that CD28 costimulation builds a platform recruiting LCK and ZAP-70 to CD3-zeta to augment CAR-NK cytotoxicity and persistence, applying CD3-zeta proximal signaling logic to engineered cells.\",\n      \"evidence\": \"CAR-NK cells with varied costimulatory domains, Co-IP of LCK/ZAP-70 with CD3-zeta, cytotoxicity assays, and xenograft models\",\n      \"pmids\": [\"38900051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CD28 acts on CD3-zeta directly or via complex remodeling unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CD3-zeta transmembrane and cytoplasmic conformational states are coupled to ITAM phosphorylation order, partner-receptor selection, and the balance among its many degradation pathways remains unresolved at structural and quantitative levels.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic structure linking TM packing to signaling-competent complexes\", \"Quantitative hierarchy among CD45, caspase-3, LAPTM5, and arginine-controlled regulation in vivo undefined\", \"Neuronal upstream ligands and effectors of CD3-zeta unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 8, 16, 24]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 16, 42, 49]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 3, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 26, 39]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [3, 45]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [39]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [21, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 8, 16, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 16, 39]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [12, 13, 23]}\n    ],\n    \"complexes\": [\"TCR/CD3 complex\"],\n    \"partners\": [\"ZAP-70\", \"LCK\", \"CD45\", \"LAPTM5\", \"CD16\", \"TREM-2\", \"SAP\", \"CD4\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}